Stockwinners Market Radar for November 29, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

NOK JNPR

Hot Stocks

19:30 EDT Nokia says the company is not preparing an offer for Juniper - While Nokia does not typically comment on market rumors, given the specificity of press reports related to a potential acquisition of Juniper Networks, the company issued the following statement: "Nokia is not currently in talks with, nor is it preparing an offer for, Juniper Networks related to an acquisition of that company."
PBA

Hot Stocks

18:27 EDT Pembina Pipeline approves C$1.3B capital program for 2018 - Pembina Pipeline has approved approximately C$400M of new capital projects, as well as a capital program of approximately $1.3B for 2018. Pembina has approved the development of the company's previously proposed liquefied petroleum gas export terminal, the Prince Rupert Terminal, to be located on Watson Island, British Columbia. The Prince Rupert Terminal is expected to have a permitted capacity of approximately 25,000 barrels per day of LPG and is expected to be in service mid-2020, subject to Pembina receiving necessary regulatory and environmental approvals. The expected capital cost has been adjusted to C$250-C$270M. LPG supply for the Prince Rupert Terminal will primarily be sourced from Pembina's Redwater fractionation complex. In addition to the Prince Rupert Terminal, the board have sanctioned the development of the North Central Liquids Hub within the world class Montney formation. The estimated capital cost for this project is C$320M and is expected to be placed into service in late 2018. The company expects to fund the approximately $1.3B 2018 capital program through internally generated cash flow and debt financing.
HSKA

Hot Stocks

18:20 EDT Heska's McGinley sells 7,826 common shares - In a regulatory filing, Heska's Michael J. McGinley disclosed the sale of 7,826 common shares of the company in three tranches priced in a range of $87.0152-$88.5401 per share.
UTI

Hot Stocks

18:03 EDT Universal Technical names Jerome Grant as COO - Universal Technical has appointed Jerome Grant aas COO. In this newly created role, Grant will lead the execution of key growth initiatives, which include increasing student enrollment, moving from a campus model of large destination campuses to smaller commuter campuses, diversifying program offerings and expanding industry relationships. Grant was previously Senior Vice President, Chief Services Officer with McGraw-Hill Education and served in multiple executive roles with Pearson Education.
CE

Hot Stocks

18:01 EDT Celanese to increase prices for acetaldehyde by EUR35 per ton - Celanese Corporation will increase list and off-list selling prices for acetaldehyde. The price increase will be effective immediately, or as contracts otherwise allow.
SNPS...

Hot Stocks

17:36 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Synopsys (SNPS), up 9.5%... Tilly's (TLYS), up 8.2%... At Home Group (HOME), up 6.1%. ALSO HIGHER: Juniper Networks (JNPR), up 16.4% after CNBC reported that Nokia (NOK) was in talks to buy Juniper... Adamis Pharmaceuticals (ADMP), up 11.4% after it submitted a prior approval supplement to the FDA for the pediatric version of Symjepi... Caesars Entertainment (CZR), up 1.9% after it announced Harrah's Las Vegas sale and leaseback agreement with VICI Properties. DOWN AFTER EARNINGS: Semtech (SMTC), down 10.5%... Box (BOX), down 5.9%... PVH Corp. (PVH), down 5.8%... Jack in the Box (JACK), down 5.6%... Guidewire (GWRE), down 4.9%... La-Z-Boy (LZB), down 3.2%... Workday (WDAY), down 1.9%. ALSO LOWER: Limelight Networks (LLNW), down 7.5% after it announced an offering of common stock for holders... Tribune Media (TRCO), down 1.2% after it filed to sell 7M shares of Class A common stock for holders.
TLYS

Hot Stocks

17:35 EDT Tilly's trades up over 8% afterhours at $14.30 following Q3 earnings beat
WDAY

Hot Stocks

17:18 EDT Workday sees Q1 subscription revenue growth 5% sequentially
TEVA

Hot Stocks

17:08 EDT NEJM publishes data on Teva's phase 3 trial of Fremanezumab - Teva Pharmaceutical Industries announced the publication of data from the pivotal Phase III HALO study evaluating the efficacy, safety and tolerability of two subcutaneous dose regimens of fremanezumab for the preventive treatment of chronic migraine. These data were published online today by the New England Journal of Medicine and will appear in a subsequent print issue. The article, "Fremanezumab for the Preventive Treatment of Chronic Migraine," reports results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group Phase III study that evaluated monthly and quarterly doses of fremanezumab versus placebo for the preventive treatment of chronic migraine in 1,130 patients. These findings, along with findings from the HALO Phase III study evaluating the efficacy, safety and tolerability of two subcutaneous dose regimens of fremanezumab for the preventive treatment of episodic migraine, were included in the Biologics License Application for fremanezumab that Teva submitted to the U.S. Food and Drug Administration in October. The most common adverse events reported in clinical trials include injection site induration, erythema, and pruritis.
SHEN MEG

Hot Stocks

17:04 EDT Shenandoah names James Woodward CFO - Shenandoah (SHEN) announced that James Woodward has joined the company as senior VP, Finance and CFO. Woodward will have responsibility for all of the accounting and finance functions of the Shentel organization. Woodward has 34 years of financial, accounting and operational experience. He most recently served as senior VP, CFO of Media General (MEG).
AMGN

Hot Stocks

17:01 EDT Amgen: STRIVE results show significant reduction in mean monthly migraine days - Amgen announced that the New England Journal of Medicine published positive results from the six-month Phase 3 STRIVE study evaluating Aimovig versus placebo for the prevention of episodic migraine. Aimovig delivered clinically meaningful and statistically significant differences from placebo for all primary and secondary endpoints in the study. Patients taking Aimovig experienced a significant reduction in mean monthly migraine days and were significantly more likely to achieve a 50 percent or greater reduction in monthly migraine days than those taking placebo. Patients reported significant improvements on key measures assessing the impact of migraine on their lives when taking Aimovig, based on the Migraine Physical Function Impact Diary - a novel patient-reported outcomes instrument validated to specifically measure the impact of migraine on physical functioning. Aimovig is the first and only fully human monoclonal antibody designed to specifically block the calcitonin gene-related peptide receptor; CGRP plays a critical role in migraine activation. "STRIVE is the first fully reported Phase 3 study of the CGRP pathway monoclonal antibodies, and it clearly shows that blocking this pathway can reduce the impact of migraine," said Peter Goadsby, M.D., Ph.D., FAHS, director, NIHR-Wellcome Trust King's Clinical Research Facility and professor of Neurology, King's College Hospital, London. "The results of STRIVE represent a real transition for migraine patients from poorly understood, repurposed treatments, to a specific migraine-designed therapy. STRIVE, as with the monoclonal antibody developments generally, represents an incredibly important step forward for migraine understanding and migraine treatment."
ELY

Hot Stocks

17:01 EDT Callaway Golf announces investor meeting with D.A. Davidson - Callaway Golf Company announced that it will be meeting with analysts and investors in New York, New York on Wednesday, November 29 through Friday, December 1, 2017.
DHIL

Hot Stocks

16:55 EDT Diamond Hill chairman sells 13,481 common shares - In a regulatory filing, Diamond Hill Investment chairman Roderick H. Dillon Jr. disclosed the sale of 13,481 common shares of the company in three tranches priced in the range of $215.18-$216.18 per share.
EEP

Hot Stocks

16:52 EDT Enbridge Energy Partners sees FY18 DCF $775M-$825M - "EEP's business outlook for the 2018 - 2020 planning period remains strong," the company said. "The Lakehead system is expected to continue to deliver stable, low-risk regulated cash flow, and the volume outlook on the North Dakota assets is expected to remain robust. Cash flow growth throughout the period will be underpinned by various sources, including rising contracted volumes on the Bakken Pipeline System and higher toll surcharges on its existing 25% interest in the Mainline Expansion Project when it fully enters service. In addition, EEP holds purchase options under existing joint funding arrangements to acquire additional interests in three projects at net book value aggregating to $1.6B, namely: 20% of the Bakken Pipeline System investment, 15% of the Mainline Expansion Project and 39% of the Line 3 Replacement Program." The Partnership expects 2018 Distributable Cash Flow to be in a range of $775M-$825M after taking into account DCF attributable to Non-Controlling Interests. DCF also assumes core maintenance capital expenditures of approximately $40M. EEP expects annual total distribution coverage in 2018 of approximately 1.2x. EEP will target distribution coverage ratios similar to these levels through the 2020 planning horizon. The Partnership also expects to grow its distributable cash flow per unit by approximately 3% per year on average through this period.
LCI

Hot Stocks

16:51 EDT Lannett announces agreement for authorized generic version of Toprol-XL - Lannett has entered into an agreement with Aralez Pharmaceuticals Trading DAC, an Irish designated activity company, to become the exclusive distributor in the U.S. of the authorized generic version of Toprol-XL Extended Release Tablets in 25 mg, 50 mg, 100 mg and 200mg. For the 12 months ended September 2017, total U.S. sales at Average Wholesale Price of Metoprolol Succinate extended release tablets 25 mg, 50 mg, 100 mg and 200 mg were approximately $690M, according to IMS. Financial terms were not disclosed. Metoprolol Succinate extended release is a beta-blocker used to treat chest pain, heart failure and high blood pressure.
SEP

Hot Stocks

16:50 EDT Spectra Energy Partners sees FY18 distributable cash flow $1.63B-$1.67B - In its FY18 business outlook, the company states: "Spectra Energy Partners' financial and business outlook for the 2018 - 2020 period continues to be strong. SEP's earnings and cash flow growth are supported by more than $2 billion of projects placed into service in 2017 and an expected incremental $2.5 billion of secured projects to be placed into service over the 2018 - 2019 timeframe, most notably NEXUS and the completion of Atlantic Bridge. Expansion capex net of contributions from non-controlling interests is expected to be $1.4 billion in 2018. Strong gas market fundamentals and SEP's asset footprint connecting to major demand markets and multiple diverse supply basins are expected to provide continued growth opportunities for SEP over the foreseeable future in areas such as the Northeast and Gulf Coast regions of the U.S."
ENB

Hot Stocks

16:48 EDT Enbridge raises quarterly dividend 10% to 67.1c - Dividend will be payable on March 1, 2018, to shareholders of record on February 15, 2018. Enbridge expects to continue to deliver annual dividend growth of 10% through 2020, which is expected to result in a dividend payout through the planning horizon of below 65% of ACFFO/share.
CB

Hot Stocks

16:46 EDT Chubb estimates Q4 losses attributable to natural catastrophes at $320M pre-tax - Chubb Limited announced preliminary loss estimates in the fourth quarter of 2017 attributable to natural catastrophes, including the California wildfires, of approximately $320 million pre-tax, or $249 million after tax. Insured losses for the California wildfires are currently estimated at approximately $280 million pre-tax, or $215 million after tax. The company also reported that all other natural catastrophe net insured losses to date in the fourth quarter are estimated at approximately $40 million pre-tax, or $34 million after tax.
CHDN

Hot Stocks

16:46 EDT Churchill Downs to sell Big Fish Games to Aristocrat Technologies for $990M - Churchill Downs announced it has signed a definitive agreement to sell its mobile gaming subsidiary, Big Fish Games, to Aristocrat Technologies, an indirect, wholly owned subsidiary of Aristocrat Leisure Limited, an Australian corporation, in an all-cash deal for $990M. The sale has been approved by the board of CDI and is subject to customary regulatory approvals and other closing conditions and is expected to close in the first calendar quarter of 2018. Proceeds from the transaction will be used for general corporate purposes, which may include investments to support organic growth and acquisitions, debt reduction and share repurchases. The CDI board has approved up to $500M of share repurchases from the proceeds of the Big Fish sale.
JNPR NOK

Hot Stocks

16:46 EDT Juniper up 21% to $35.89 after CNBC reports Nokia in talks to buy company
CZR

Hot Stocks

16:37 EDT Caesars announces Harrah's Las Vegas sale and leaseback agreement with VICI - Caesars Entertainment announced definitive agreements to sell and leaseback the real estate assets associated with Harrah's Las Vegas to VICI Properties and to acquire adjacent land from VICI to develop a planned new 300,000 square foot convention center. Under the terms of the Harrah's sale agreement, Caesars will receive $1.14B in cash in return for Harrah's Las Vegas' real estate assets. Under the terms of the convention center agreement, Caesars will acquire 18.4 acres of adjacent land from VICI as part of Caesars Entertainment's plan to develop a new 300,000 square-foot convention center. The proceeds of the Harrah's Las Vegas sale will be the primary source of funds for the previously announced purchase of Centaur Holdings. The planned convention center is expected to become a leading destination for meetings on the Las Vegas Strip. Caesars will continue to operate Harrah's Las Vegas, including gaming, hotel operations and all other amenities. As part of the sale and leaseback transaction, Caesars and VICI will enter into a 15-year lease for Harrah's Las Vegas under which Caesars will pay initial annual rent of $87.4M. The rent will increase contractually in subsequent years. VICI has secured committed financing to fund the purchase. Caesars will have the right to require VICI to purchase the convention center and lease it back to Caesars, and in the event Caesars does not exercise its put right, VICI will have an option to acquire the convention center and lease it back to Caesars. The transactions are expected to close by year end.
SNPS

Hot Stocks

16:36 EDT Synopsys up 10% to $95.20 after Q4 results, Q1 guidance top estimates
DIS

Hot Stocks

16:33 EDT Disney announces dividend increase to 84c per share - The Walt Disney Company board announced a semi-annual cash dividend of 84c per share, payable January 11, 2018 to shareholders of record at the close of business on December 11. The company last paid a semi-annual dividend of 78c per share in July. "Disney's incomparable collection of iconic brands and franchises continues to deliver strong returns, and we are pleased to increase our dividend to shareholders to $0.84 per share," said Robert Iger, chairman and CEO, Disney. "This payment brings our total dividends for fiscal 2017 to $1.62 a share."
HCHC

Hot Stocks

16:32 EDT HC2 Holdings broadcasting subsidiary acquires Azteca America - HC2 Holdings announced that its subsidiary, HC2 Network , has acquired Azteca America, a Spanish-language broadcast network, from affiliates of TV Azteca, S.A.B. de C.V, one of the two largest producers of Spanish-language television programming in the world. In addition, HC2 Network has signed a definitive acquisition agreement with Northstar Media, a licensee of numerous broadcast television licenses in the United States. Under the agreement with Azteca, which closed today, HC2 Network acquired Azteca America, a Spanish-language broadcast network providing original content to the Hispanic audience in the United States. Under the agreement with Northstar, HC2 Network will acquire Northstar's broadcast television stations, which carry Azteca America programming. The Azteca transaction extends to the acquisition of professional staff across the U.S. involved in programming, marketing, advertising sales, finance and operations. The Northstar transaction, which is subject to approval by the Federal Communications Commission, as well as other customary closing conditions, would result in HC2 Network acquiring 19 television stations, including two full-power stations, eight Class A stations and eight low power television stations, along with a channel share agreement for the full-power license of KEMO-TV in San Francisco. In combination with HC2's previously announced acquisitions of a controlling equity interest in DTV America Corporation, which currently carries Azteca video programming in 10 markets, and of the broadcasting assets of Mako Communications, LLC and its affiliates, Three Angels Broadcasting Network, Inc., and other station licensees, the acquisition of the 19 Northstar television stations would expand HC2's broadcasting network to 113 operating stations, including three full-power stations (inclusive of the channel-share agreement for KEMO-TV in San Francisco), 27 Class A stations and 83 LPTV stations, in over 80 markets across the United States. In addition, the acquisitions increase HC2's construction permits to 475, allowing for further buildout of coverage across the United States. The Azteca transaction also includes multi-year programming and services agreement that provides HC2 with access to TV Azteca's current programming and library in Mexico, including top entertainment shows, talk shows, reality programs, network and local news, as well as telenovelas and other scripted series. Financial terms of the transactions were not disclosed.
TXMD

Hot Stocks

16:32 EDT TherapeuticsMD resubmits NDA for TX-004HR with FDA - TherapeuticsMD announced that it has resubmitted the New Drug Application for TX-004HR, the company's investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate-to-severe vaginal pain during sexual intercourse, a symptom of vulvar and vaginal atrophy due to menopause, with the U.S. Food and Drug Administration. The company expects to learn of the acceptance of the NDA resubmission within 30 calendar days. The FDA will classify the NDA resubmission as Class 1 or Class 2 upon acceptance of the resubmission. A Class 1 review constitutes a two-month review from the date of resubmission and a Class 2 review constitutes a six-month review from the date of resubmission.
NP

Hot Stocks

16:31 EDT Neenah Paper announces $25M share buyback
NP

Hot Stocks

16:31 EDT Neenah Paper raises quarterly dividend to 41c from 37c
FWP

Hot Stocks

16:31 EDT Forward Pharma files further submissions in proceeding for '355 patent - Forward Pharma A/S announced the filing of further written submissions in the European Opposition Proceeding for the EP2801355 patent with the Opposition Division of the European Patent Office. The filing will become publicly available via the European Patent Register. An oral hearing is currently scheduled for January 29-30, 2018. The Opposition Division typically issues a decision at the conclusion of the oral hearing, with more detailed reasons for the decision being issued in written form later. There is the possibility to appeal the decision of the Opposition Division to the Technical Board of Appeal, with an expected duration of the appeal process of an additional 2-3 years.
SMTC

Hot Stocks

16:24 EDT Semtech down over 10% at $32.85 following lower than expected Q4 guidance
LZB

Hot Stocks

16:22 EDT La-Z-Boy raises quarterly dividend to 12c from 11c - The dividend will be paid on December 20, 2017, to shareholders of record as of December 11, 2017.
ATSG BA

Hot Stocks

16:19 EDT Air Transport Services signs Boeing lease agreement with Air Incheon - Air Transport Services Group (ATSG) announced the signing of a new lease agreement with Air Incheon for one Boeing (BA) 767-300 converted freighter and an option for a second, both for 2018 delivery, along with the expansion of its dry-leased 767-300 freighter fleet with three deliveries in November. The company said that its ATSG West Leasing Limited subsidiary in Ireland has committed to lease one converted Boeing 767-300 freighter to Air Incheon of South Korea for a multi-year term anticipated to commence on March 31, 2018. ATSG West Leasing has also granted Air Incheon an option to lease a second 767-300 freighter for delivery later in 2018.
KRG

Hot Stocks

16:18 EDT Kite Realty Group increases quarterly dividend 5% - Kite Realty Group Trust announced that its board declared a quarterly cash distribution of 31.75c per common share for the quarter ended December 31, which represents an increase of 5.0% compared to the dividend paid for the prior quarter. This distribution will be paid on or about January 12, 2018, to shareholders of record as of January 5, 2018.
PRA

Hot Stocks

16:17 EDT ProAssurance declares special dividend of $4.69 per share - ProAssurance declared a special dividend of $4.69 per share and a regular dividend of 31c per share. Both will be paid on January 10, 2018 to shareholders who own stock as of December 21, 2017.
UPS

Hot Stocks

16:17 EDT UPS appoints Scott Price as Chief Transformation Officer - UPS (UPS) announced Scott Price will join the company as Chief Transformation Officer, effective December 11. He will also join the UPS Management Committee, the company's senior-most leadership group. Price is currently executive VP, Global Leverage for Walmart (WMT).
FFBC

Hot Stocks

16:16 EDT First Financial Bancorp-MainSource Financial Group merger recommended by ISS - First Financial Bancorp announced that Institutional Shareholder Services and Glass, Lewis & Co. have both recommended that First Financial shareholders vote for the proposed merger with MainSource Financial Group. In its report, Glass Lewis stated, "We find the proposed merger both strategically and financially compelling, at a fair and reasonable valuation for First Financial shareholders. The merger strengthens and expands the company's presence and franchise in a complementary manner and presents the opportunity to achieve cost savings and efficiencies (...)The company forecast $43M in annual pre-tax cost savings and has articulated a strong strategic rationale. Moreover, the transaction is expected to be accretive to EPS starting in 2018. As such, support for the proposal is warranted." The merger and related proposals have been unanimously approved by the boards of directors of both companies. The proposed merger is expected to close early in 2018.
GNW

Hot Stocks

16:16 EDT Genworth, Oceanwide extend merger agreement - Genworth Financial and China Oceanwide Holdings Group Co. announced they have agreed to a second waiver and agreement of each party's right to terminate the previously announced merger agreement. The second waiver and agreement extends the previous deadline of Nov. 30, 2017, to April 1, 2018, and allows additional time for regulatory reviews of the transaction. As previously announced, Genworth and Oceanwide withdrew their most recent joint voluntary notice to CFIUS with the intent to refile with additional mitigation approaches, including potentially working with a U.S. third-party service provider. Both parties are fully committed to continuing to work on robust mitigation proposals; however, there can be no assurances that CFIUS will ultimately agree to clear a transaction between Genworth and Oceanwide on terms acceptable to the parties or at all. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China and other international jurisdictions and other closing conditions. Genworth and Oceanwide remain committed to satisfying the closing conditions under the merger agreement as soon as possible.
RVNC

Hot Stocks

16:15 EDT Revance plans for RT002 injectable to treat cervical dystoniato go into Phase 3 - Revance Therapeutics announced the completion of its end-of-phase 2 meeting with the FDA along with receipt of scientific advice from the Europe Medicines Agency regarding DaxibotulinumtoxinA for Injection for the treatment of cervical dystonia, a movement disorder of the neck, in adults. Based on the Phase 2 safety and efficacy results, along with guidance from the FDA and EMA, Revance plans to proceed to a Phase 3 program in cervical dystonia. Revance's Phase 3 program will be conducted at multiple sites in the U.S., Canada and Europe, and will be designed to fulfill regulatory submission requirements in both the U.S. and Europe. Revance is finalizing the trial protocols for the pivotal program, which is planned to commence in 2Q18. In May, the company reported that in a Phase 2 trial, RT002 appeared to be generally safe and well-tolerated, delivered clinically significant improvement in signs and symptoms of cervical dystonia in patients, and demonstrated duration of effect of at least 24 weeks. Earlier this month, the company announced that the FDA granted orphan drug designation for RT002 to treat cervical dystonia.
BPI

Hot Stocks

16:14 EDT California AG sues Ashford, Bridgepoint over allegedly misleading students - California Attorney General Xavier Becerra announced that he is suing Ashford University, an online for-profit school based in San Diego, and its parent company Bridgepoint Education for engaging in unlawful business practices. In the lawsuit, Attorney General Becerra alleges that Ashford made false promises and furnished faulty information to students to persuade them to enroll. It also used illegal debt collection practices when students struggled to pay their bills. Attorney General Becerra seeks restitution for students, a permanent injunction prohibiting similar activities in the future, and civil penalties from Ashford University. "No school should ever steal the American Dream from its students, but that is exactly what Ashford University did," said Attorney General Becerra. "Ashford University preyed on veterans and people of modest means. This for-profit college illegally misled students about their educational prospects and unfairly saddled them with debt. In today's economy, college is too pivotal and precious to let a predatory for-profit company swindle our daughters and sons out of the higher education they'll need to get ahead." Reference Link
VZ

Hot Stocks

16:11 EDT Verizon to launch 5G residential broadband services in up to 5 markets in 2018 - Verizon Communications announced it will launch wireless residential broadband services in three to five U.S. markets in 2018. Verizon's first commercial launch is planned to be in Sacramento, Calif., in the second half of 2018. Details of that launch, and the announcement of additional markets, will be provided at a later date. Verizon has successfully trialed 5G residential applications in 11 markets in 2017. The commercial launch is based on customer experience and on Verizon's confidence in new technology powered by millimeter-wave spectrum. Verizon estimates the market opportunity for initial 5G residential broadband services to be approximately 30M households nationwide. The 5G commercial launch will not have a material impact on Verizon's consolidated capital expenditures in 2018. The company expects its full-year 2018 capital spending program to be consistent with the past several years.
SNPS

Hot Stocks

16:09 EDT Synopsys co-CEO says 'saw revenue strength across the board' - "Synopsys reported another excellent fiscal year, with double-digit revenue and non-GAAP earnings growth. We saw revenue strength across the board, augmented by upside from hardware and IP, and an approximate $150 million increase in non-cancellable backlog," said Aart de Geus, chairman and co-CEO of Synopsys. "Our EDA and IP products are essential for customers building chips to bring about the Digital Intelligence age. In addition, we are making great progress in scaling our software security platform both organically and through the recently announced planned acquisition of Black Duck Software. Overall, we continued to drive long-term shareholder value by balancing our investment priorities while executing $400 million in share repurchases during fiscal year 2017."
ADMP

Hot Stocks

16:08 EDT Adamis submits prior approval supplement to FDA for pediatric version of Symjepi - Adamis Pharmaceuticals announced the submission of a prior approval supplement to the FDA for a pediatric version of Symjepi. Symjepi Injection 0.3mg is an FDA-approved product, for the emergency treatment of allergic reactions including anaphylaxis, designed for patients weighing 66 pounds or greater. The pediatric version is intended to potentially treat patients weighing 33-65 pounds. Both Symjepi products are intended to provide two single-dose syringes of epinephrine, which is considered the drug of choice for immediate administration in acute anaphylactic reactions to allergic reaction to foods, insect stings or bites, drugs and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
TCON

Hot Stocks

16:06 EDT TRACON Pharmaceuticals doses 1st patient in Phase 1b study of TRC105 with Opdivo - TRACON Pharmaceuticals announced that the first patient has been dosed in its Phase 1b clinical trial of TRC105 in combination with Opdivo in patients with non-small cell lung cancer. The primary objectives of the Phase 1b study are to assess the safety of TRC105 when given with Opdivo, determine its recommended Phase 2 dose with Opdivo and evaluate the response rate. The trial incorporates tumor biopsy testing to correlate tumor myeloid cell infiltration with response, in order to allow for potential biomarker-directed therapy of lung cancer patients.
ZOES

Hot Stocks

16:03 EDT Misada Capital Flagship Fund reports 7.4% passive stake in Zoe's Kitchen
GNMSF JNJ

Hot Stocks

15:47 EDT Genmab reports achievement of $20M milestone in Janssen collaboration - Genmab (GNMSF) announced that its partner, Janssen Biotech (JNJ), has triggered a $20M milestone payment, based on progress made in the first Phase III study in a disease other than multiple myeloma. The milestone payment relates to progress in the ongoing Phase III ANDROMEDA study of daratumumab in combination with cyclophosphamide, bortezomib and dexamethasone in amyloidosis. Also, Genmab is improving its 2017 financial guidance last published on November 14 due to the inclusion of the daratumumab milestone. Genmab now expects 2017 revenue to be in the range of DKK 2.24B-2.44B, an increase of DKK 130M compared to the previous guidance. As a result of the increased revenue, the company now expects operating income for 2017 to be approximately DKK 1.19B-1.39B, compared to DKK 1.06B-1.26B in the previous guidance.
ASNS

Hot Stocks

15:41 EDT New Enterprise Associates reports 14.6% stake in Arsanis
STM AMZN

Hot Stocks

15:03 EDT STMicroelectronics announces collaboration with Amazon Web Services - STMicroelectronics (STM) announced its collaboration with Amazon Web Services (AMZN) on Amazon FreeRTOS, the latest addition to the AWS Internet of Things solution, offering a complete IoT node-to-cloud solution to the market. "ST's collaboration with AWS speeds designers' efforts to create easily connectable IoT nodes with the combination of ST's semiconductor building blocks and Amazon FreeRTOS, which extends the leading free and open-source real-time operating-system kernel for embedded devices with the appropriate libraries for local networking, cloud connectivity, security, and remote software updates," the company stated.
AMPH PFE

Hot Stocks

14:51 EDT Amphastar: FDA approves Medroxyprogesterone Acetate Injectable Suspension - Amphastar Pharmaceuticals (AMPH) announced that the U.S. Food and Drug Administration granted approval of two abbreviated new drug applications for Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/mL, 1mL vial, and 1mL prefilled syringe, respectively, indicated for the prevention of pregnancy. Amphastar's newly approved products were determined by the FDA to be therapeutically equivalent to Depo-Provera Contraceptive Injection sold in the United States by Pfizer (PFE). Amphastar's CEO, Dr. Jack Zhang, stated: "We are excited about the approval of Medroxyprogesterone Acetate, which further expands the product offerings in our generic injectable portfolio and highlights our commitment and capability of bringing complex generic drugs to the market." Amphastar anticipates launching its product in the first quarter of 2018.
CFFI

Hot Stocks

14:42 EDT C&F Financial increases quarterly dividend 3% to 34c per share - The board of C&F Financial Corporation has declared a regular cash dividend of 34c per common share, which is payable January 1, 2018 to shareholders of record on December 15, 2017. This dividend represents a 3.0% increase over the prior quarter's dividend amount of 33c per common share.
BTC BITCOIN

Hot Stocks

14:36 EDT Bitcoin reverses sharply, drops below $10,000 - Bitcoin, which had been higher for most of the day, has now moved down 3% on the day to trade near $9,596, according to CoinDesk data.
BTC BITCOIN

Hot Stocks

14:36 EDT Bitcoin reverse sharply, drops below $10,000 - Bitcoin, which had been higher for most of the day, has now moved down 3% on the day to trade near $9,596, according to CoinDesk data.
AMZN

Hot Stocks

14:15 EDT Amazon announces AWS DeepLens, 'world's first' deep learning wireless camera - At AWS Re:Invent, Amazon Web Services announced five new machine learning services. Amazon SageMaker is a fully managed service for developers and data scientists to quickly build, train, deploy, and manage their own machine learning models. AWS' four new application services allow developers to build applications that "emulate human-like cognition," said the company. Amazon Transcribe is for converting speech to text; Amazon Translate is for translating text between languages; Amazon Comprehend is for understanding natural language; and, Amazon Rekognition Video is a new computer vision service for analyzing videos in batches and in real-time. AWS also introduced AWS DeepLens, which the company described as "a deep learning-enabled wireless video camera that can run real-time computer vision models to give developers hands-on experience with machine learning."
AMZN

Hot Stocks

14:15 EDT Amazon Web Services announces five new machine learning services - Amazon Web Services announced five new machine learning services and a deep learning-enabled wireless video camera for developers. Amazon SageMaker is a fully managed service for developers and data scientists to quickly build, train, deploy, and manage their own machine learning models. AWS also introduced AWS DeepLens, a deep learning-enabled wireless video camera that can run real-time computer vision models to give developers hands-on experience with machine learning. And, AWS announced four new application services that allow developers to build applications that emulate human-like cognition: Amazon Transcribe for converting speech to text; Amazon Translate for translating text between languages; Amazon Comprehend for understanding natural language; and, Amazon Rekognition Video, a new computer vision service for analyzing videos in batches and in real-time.
AMZN

Hot Stocks

13:57 EDT AWS announces new database capabilities for Amazon Aurora, DynamoDB - At AWS re:Invent, Amazon Web Services announced new database capabilities for Amazon Aurora and Amazon DynamoDB, and introduced Amazon Neptune, which it calls "AWS's new fast, reliable, and fully managed graph database service that makes it easy for developers to build and run applications that work with highly connected datasets." Amazon Aurora now includes the ability to scale out database reads and writes across multiple data centers for even higher performance and availability. Amazon DynamoDB is now the first fully managed database service that provides true multi-master, multi-region read and writes, offering high-performance and low-latency for globally distributed applications and users, the company said.
AMZN

Hot Stocks

13:56 EDT Amazon announces Elastic Container Service for Kubernetes, Fargate - Amazon Web Services announced two new arrivals to complement its existing popular Amazon Elastic Container Service, or Amazon ECS, and make it easier than ever to deploy, manage, and scale container workloads on AWS. Amazon Elastic Container Service for Kubernetes brings Kubernetes to AWS as a fully managed service, making it easy for customers to run Kubernetes applications on AWS without the need to become experts in operating Kubernetes clusters. AWS also introduced a new capability called AWS Fargate that allows customers to launch and run containers without provisioning or managing servers or clusters. "While we have over a hundred thousand active Amazon ECS clusters running on AWS and more customers running Kubernetes on AWS than on any other cloud, customers have also asked us to build a managed Kubernetes service like we have with Amazon ECS," said Deepak Singh, GM of Containers and High Performance Computing Services, AWS. "Not only have we delivered on this request with Amazon EKS, but we've also made managed containers easier to use than ever before by launching AWS Fargate to allow developers to run containers at the task level rather than having to think about servers or clusters."
S

Hot Stocks

13:53 EDT Sprint adds new Point of Presence in Denver, Colorado - Sprint announced that it is continuing its strategy to expand in major carrier hotels to broaden its network and provide access at the lowest cost. The latest effort in this expansion added a new Point of Presence at 910Telecom in Denver, Colorado. Sprint is now able to provide access to its wireline network and connectivity solutions to customers that are co-located in the data center. Sprint can now provide access to Global MPLS and Dedicate IP customers via a direct presence at 910Telecom. The new PoP provides 910Telecom's carrier and enterprise customers access to port speed up to 100 Gig per second.
KMI

Hot Stocks

13:50 EDT Canadian ministry supports Kinder Morgan's Trans Mountain appeal - Jim Carr, minister of Canada's Ministry of Natural Resources, released a statement on Canada's letter to the National Energy Board supporting the establishment of a Standing Panel to determine Kinder Morgan's Trans Mountain's compliance with provincial and municipal permits: "Canadians want an energy system that creates good, middle-class jobs while protecting and preserving the environment for future generations. Yesterday, Canada filed a letter to the National Energy Board, indicating the Government's support for establishing a Standing Panel to determine ongoing compliance by Kinder Morgan for the project conditions of the Trans Mountain Pipeline Expansion. The Government has taken an important step to ensure that when a natural resource project is approved, it proceeds in a timely fashion and continues to generate economic benefits for all Canadians. The Government is supportive of establishing a process that would assist in resolving any conflicts over the issuance of municipal or provincial permits and avoid unnecessary delays to project construction or regulatory compliance." Reference Link
INNV

Hot Stocks

13:36 EDT Innovus Pharmaceuticals partner Bio Task receives approval for Zestra by NPRA - Innovus Pharmaceuticals announced that its partner Bio Task SDN BHD received approval to commercialize Innovus Pharma's product Zestra as a Cosmetic from the National Pharmaceutical Regulatory Agency, Ministry of Health, Malaysia for arousal and desire. Innovus Pharma signed in November 2015 an exclusive license and distribution agreement with Bio Task, a company based in Malaysia, for the commercialization of Zestra for arousal and desire in women and for Zestra Glide as a lubricant, Sensum+ to increase penile sensitivity, EjectDelay for treatment of Premature Ejaculation and for Vesele to increase sexual and cognitive functions in men and women. Zestra is currently approved to be commercialized in 37 countries in the world namely, in Canada, the 28 countries of the European Union, Australia, New Zealand, India, Hong Kong, the United Arab Emirates, South Korea, Morocco and Malaysia.
AGN RVNC

Hot Stocks

13:18 EDT Before the Move: Watch Allergan into Revance 'better Botox' trial data - Shares of Allergan (AGN) are on the rise after Morgan Stanley analyst David Risinger upgraded the stock to Overweight, a buy-equivalent rating as he believes the shares can outperform over time and fears about a "better Botox" from a competitor may be overdone. BUY ALLERGAN: In a research note this morning, Morgan Stanley's Risinger upgraded Allergan to Overweight from Equal Weight while maintaining a $200 price target on the stock. The analyst told investors that Allergan's risk-reward looks favorable following a significant stock decline due to reductions in out-year estimates, pipeline concerns, competitive threats to Botox, and negative perception associated with licensing of Restasis patent to an Indian tribe. Risinger believes the negatives have largely been priced into the stock, and given investor concerns about the safety of new drug candidates for migraine and eye disease, he sees the risk-reward on 2018 Phase 3 pipeline news flow as skewed to the upside. Additionally, the analyst pointed out that he thinks investor enthusiasm for rapastinel for severe depression will rise as three Phase 3 studies reach their conclusion at the end of 2018. Compelling Phase 2 data indicated that rapastinel may be a blockbuster, he contended. Meanwhile, Risinger believes fears about a "better Botox" may be overdone. While Revance's (RVNC) botulinum toxin RT002 Phase 3 data is expected "any day now," he thinks it could be difficult for the company to demonstrate that RT002 is materially longer-lasting than Botox, which has been a concern for Allergan investors. Further, the analyst pointed out that mechanistically it would be difficult to create a significantly longer-lasting Botox because botulinum toxin gradually loses efficacy over four months due to neuronal regeneration. If he is correct, Allergan shares could benefit, he said. PRICE ACTION: In afternoon trading, shares of Allergan have gained almost 4% to $178.14. "Before the Move" is The Fly's recurring series of exclusive stories that identify potentially market moving events, along with analyst predictions, ahead of the news.
AVH

Hot Stocks

13:16 EDT Avianca, Kingsland Holdings agree to withdraw lawsuits - Avianca Holdings S.A. and Kingsland Holdings Ltd. agreed to withdraw their respective lawsuits filed in New York State Supreme Court. The parties jointly filed a stipulation with the court dismissing the actions without prejudice. Avianca continues to negotiate a strategic alliance with United Airlines and hopes to finalize an agreement by the end of the year. "As we've said all along, Kingsland's lawsuit was meritless and filed prematurely, and we are pleased that the parties have reached an agreement to dismiss both actions," said Avianca CEO Hernan Rincon. "Avianca is now looking beyond the litigation, and we are pleased that negotiations with United are progressing. Moving forward, Avianca will continue to focus on serving our passengers, advancing our strategic goals, and developing our business across Latin America."
RST AMZN

Hot Stocks

13:13 EDT Rosetta Stone weakness attributed to Amazon worries - Shares of Rosetta Stone (RST) have moved lower in early afternoon trading amid headlines from Amazon's (AMZN) AWS re:Invent conference regarding the company's launch of an AI translation and transcription service. The service is called Amazon Translate, according to headlines from Bloomberg regarding the AWS developers and users conference. In afternoon trading, Rosetta Stone shares are down about 2% to $11.88.
ROKU

Hot Stocks

12:55 EDT Needham analyst Martin says Roku shares will 'quadruple' - Needham analyst Laura Martin said on CNBC that shares of Roku will "quadruple." The analyst defended during a live appearance her $50 price target on the stock to Citron Research's Andrew Left, who has a short position in the name. Roku in midday trading is down 83c to $45.60.
ROKU

Hot Stocks

12:47 EDT Citron's Left says 'absolutely' short shares of Roku - Andrew Left of Citron Research is speaking on CNBC.
ROKU

Hot Stocks

12:45 EDT Citron's Left says Needham's $50 target on Roku is 'price chasing' - Andrew Left of Citron Research is speaking on CNBC.
T TWX

Hot Stocks

12:36 EDT AT&T CEO says 'ready to litigate,' government should be too - AT&T (T) CEO Randall Stephenson continues being interviewed at the Economic Club of New York.
T TWX

Hot Stocks

12:32 EDT AT&T CEO says committed to 'no blackout' rule - AT&T (T) CEO Randall Stephenson said that the company has committed, as part of its negotiations to receive clearance to buy Time Warner (TWX), to a "no blackout" rule so that channels such as TNT and CNN cannot be pulled off the air during contract negotiations with cable and satellite TV providers. Stephenson is being interviewed at the Economic Club of New York by CNBC's Becky Quick.
AMZN LULU

Hot Stocks

12:08 EDT Analyst sets $1,500 target on Amazon after e-commerce leader's biggest day ever - Amazon (AMZN) has confirmed that this past Cyber Monday was the company's single biggest shopping day worldwide in its history, surpassing Prime Day for most products ordered. Meanwhile, DA Davidson analyst Tom Forte raised his price target on Amazon to $1,500, citing rising confidence in the company's ability to leverage physical stores to maximize its long-term revenue growth. SALES RECORD: Amazon has announced that Cyber Monday was the single biggest shopping day worldwide in the company's history, and the biggest day ever for small businesses and entrepreneurs selling on Amazon. "Amazon customers shopped at record levels during the Turkey 5, ordering hundreds of millions of products from toys to fashion to electronics and Amazon devices," stated Jeff Wilke, CEO Worldwide Consumer. Throughout the five day period around the holiday, Amazon customers worldwide ordered at record levels, and Cyber Monday 2017 is now the single biggest shopping day in Amazon's history, surpassing Prime Day 2017. Additionally, the e-commerce giant said that with new lower prices on turkeys and Prime members receiving an even deeper discount this year, Whole Foods Market in the U.S. broke its all-time record of turkeys sold during the Thanksgiving season. Amazon also announced its best-ever holiday shopping weekend for devices, with millions of Amazon devices sold between Thanksgiving and Cyber Monday. Echo Dot and Amazon Fire TV Stick with Alexa Voice Remote were not only the best-selling Amazon devices, but they were the best-selling products from any manufacturer in any category across all of Amazon.com. TARGET TO $1,500: While acknowledging that Amazon has reported record holiday sales, DA Davidson's Forte told investors that he was focusing on the company's physical store efforts and raising his price target on the shares to $1,500 from $1,300. The analyst believes Amazon's increased physical footprint is "THE story of its 2017 holiday sales" and an indication of things to come as the company increasingly leverages physical stores to increase its revenue growth and wallet share. In the future, Forte believes the company will roll out its Amazon Go proprietary technology to enable consumers to skip the checkout counter for the portion of Whole Foods stores where consumers can purchase prepared foods, and consumers will be able to pick up online purchases and process returns at its Whole Foods locations. Additionally, the analyst told investors that he expects the e-commerce giant to leverage its Whole Foods locations with new efforts, such as an Amazon pharmacy, and sees the potential for Amazon to operate gas stations to enable consumers to save money on gas. Lastly, Forte noted that he looks for it to acquire an apparel retailer, such as lululemon (LULU), to add physical stores to advance its apparel sales, especially in women's apparel. He reiterated a Buy rating on Amazon shares. PRICE ACTION: In afternoon trading, shares of Amazon have dropped almost 4% to $1,146.57 amid broader weakness in the Nasdaq and the Internet space.
GLW

Hot Stocks

12:05 EDT Corning to create 185 jobs in New York through Valor Glass investment - Corning announced an investment in Corning Valor Glass that will create 185 new jobs and support more than 380 jobs overall in the Southern Tier of New York. The new jobs will be located at the Corning Innovation Support Center in Big Flats and at Corning's Research and Development Facility at Sullivan Park in Erwin. Corning has been awarded incentives from Empire State Development, New York State's chief economic development agency, in the form of a $6M capital grant through the Upstate Revitalization Initiative to purchase manufacturing equipment and make infrastructure improvements; and tax credits through the Excelsior program. Developing and manufacturing Valor Glass in the Southern Tier is part of Corning's plan announced in July to invest $500M and create 1,000 new U.S. jobs.
TSLA

Hot Stocks

12:05 EDT EPA: Tesla Model 3 has range of 310 miles - According to the Environmental Protection Agency, Tesla's Model 3 has a confirmed range of 310 miles. The vehicle's MPGe is 131 in cities and 120 on highways, good for 126 combined, the EPA said. Reference Link
AAPL

Hot Stocks

12:02 EDT Apple issues update to address MacOS High Sierra flaw - Apple has issued a security update to address the vulnerability in MacOS High Sierra, which made it possible for anybody to log into any computer running Mac OS High Sierra by using the "root" username accompanied by a blank no password. Apple says, "A logic error existed in the validation of credentials. This was addressed with improved credential validation." Reference Link
OLBK

Hot Stocks

12:01 EDT Old Line Bank chief lending officer Burnett retires - Old Line Bank announced the retirement of Joseph E. Burnett, executive VP and chief lending officer. Burnett served in the capacity of CLO since joining the Bank in 2001. Additionally, on November 28, 2017, Old Line Bank announced the promotion of Jack Welborn to serve as CLO, effective January 2, 2018. Welborn joined Old Line Bank in 2005 as a commercial loan officer.
VIA...

Hot Stocks

11:58 EDT Viacom CEO: Content is 'essentially what Viacom is' - Speaking with CNBC's Julia Boorstin about the changes at the company and within the media landscape, Viacom (VIAB) CEO Bob Bakish said earlier that the company might do acquisitions "here and there." When asked if Bakish thinks Viacom needs to recombine with CBS (CBS), Bakish said Viacom has "plenty of opportunity in the assets we already own" and that he "feels good" about the company's assets. "Content is essentially what Viacom is," Bakish said. Reference Link
SNY

Hot Stocks

11:40 EDT Sanofi asks regulators to update dengue vaccine label to reflect new information - Sanofi will ask health authorities to update information provided to physicians and patients on its dengue vaccine Dengvaxia in countries where it is approved. The request is based on a new analysis of long-term clinical trial data, which found differences in vaccine performance based on prior dengue infection. Based on up to six years of clinical data, the new analysis evaluated long-term safety and efficacy of Dengvaxia in people who had been infected with dengue prior to vaccination and those who had not. The analysis confirmed that Dengvaxia provides persistent protective benefit against dengue fever in those who had prior infection. For those not previously infected by dengue virus, however, the analysis found that in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection. "These findings highlight the complex nature of dengue infection. We are working with health authorities to ensure that prescribers, vaccinators and patients are fully informed of the new findings, with the goal of enhancing the impact of Dengvaxia in dengue-endemic countries," said Dr. Su-Peing Ng, Global Medical Head, Sanofi Pasteur. Dengvaxia is currently indicated in most of the countries for individuals 9 years of age and older living in a dengue-endemic area. In this indicated population, Dengvaxia has been shown to prevent 93% of severe disease and 80% of hospitalizations due to dengue over the 25 month phase of the large-scale clinical studies conducted in 10 countries in Latin America and Asia where dengue is widespread.
RTN

Hot Stocks

11:23 EDT Raytheon announces agreement for Romania to buy Patriot system from U.S. - The government of Romania signed an agreement to purchase Raytheon's Patriot integrated air and missile defense system from the U.S. Army. "The agreement, formally referred to as a Letter of Offer and Acceptance, paves the way for Romania's Patriot force to rapidly reach Initial Operational Capability, and sets the stage for the U.S. government to begin contract negotiations with Raytheon...Romania's procurement of the system will help the country meet its NATO commitment to spend at least 2% of its Gross Domestic Product on defense," the company stated.
PCAR TSLA

Hot Stocks

11:20 EDT Battleground: Analysts diverge on Paccar after Tesla Semi truck reveal - This morning, Citi analyst Timothy Thein downgraded Paccar (PCAR) to Neutral, citing a lack of catalysts, while his peer at Susquehanna initiated coverage of the stock with the same rating. However, not all on Wall Street are as bearish. JPMorgan analyst Ann Duignan argued that the weakness in the shares since Tesla's (TSLA) Semi truck reveal is overdone, and reiterated a buy-equivalent rating on the stock. WEAKNESS OVERDONE: In a research note to investors, JPMorgan's Duignan pointed out that Paccar's shares have underperformed the S&P Machinery Index by 4.7% since the unveiling event for Tesla's Semi truck. The analyst views the reaction in Paccar shares as overdone, saying the likelihood of "significant disruption in the near to mid-term is limited, at most." If Tesla is to succeed in transforming the trucking industry to electric, it will likely need to partner with a company like Paccar, Duignan contended, adding that such a partnership may be a net positive for both companies. Overall, the analyst does not view the electric Semi as significant threat and rather believes it could be an upside catalyst. Duignan reiterated an Overweight rating and an $83 price target on Paccar shares. MOVING TO THE SIDELINES: Meanwhile, Citi's Thein downgraded Paccar to Neutral saying that despite the stock's year to date underperformance, he no longer sees catalysts in place to warrant a Buy rating. While the analyst expects trucking fundamentals in most of the company's major geographies to remain solid through 2018, his concern revolves more around the target multiple, as history has exhibited a fairly consistent pattern of multiple compression as North America build rates eclipse "trend" levels. Additionally, Thein pointed out that risk from electric vehicles is likely overplayed, but the overhang is still a concern. He lowered his price target on Paccar shares to $75 from $81. His peer at Susquehanna also initiated coverage of the stock with a Neutral rating and a $75 price target. While analyst Brendon Mason acknowledged Paccar's superior track record and marketplace standing, he believes there are other OEMs who are better positioned to benefit more vigorously from improving industry growth at this time. PRICE ACTION: In morning trading, shares of Paccar have gained about 1.3% to $69.40.
FOXA

Hot Stocks

11:15 EDT Fox co-chairman declines comment on asset sale speculation - 21st Century Fox Co-Chairman Lachlan Murdoch, while speaking at Business Insider's conference, declined to comment on speculation that the company may sell some of its assets. Murdoch added that the "rumors" and "gossip" in the media has created a conversation about scale.
KEYS EADSY

Hot Stocks

11:03 EDT Keysight Technologies teams with European Space Agency, Airbus SpaceTech - Keysight Technologies (KEYS) announced that the FieldFox handheld RF analyzer was used in the evaluation of the impedance of the radar antenna for icy moons exploration, or RIME, a key component of one of the ten science payloads of the European Space Agency's Jupiter icy moons explorer, or JUICE, spacecraft scheduled for launch in 2022. RIME engineers performed phase-matching and orientation tests of the RIME antenna in Heiligenberg, Germany in September 2017. They also evaluated two radar antennas, one aluminum and the other carbon fiber reinforced polymer, or CFRP, which will be used on the spacecraft. The antennas were housed on a satellite-sized enclosure, and the enclosure was lifted 300 meters in the air by helicopter to ensure low-RF coupling to the ground. Keysight's handheld FieldFox analyzer was used in remote mode to measure S-parameter characteristics of the antenna in flight as it was rotated more than 180 degrees and with the spacecraft mock-up being maneuvered by helicopter. Test data was recovered at a base station on the ground via a wireless link between the FieldFox and the ground base station. "We are pleased at being chosen as a key test solution provider for evaluation of the RIME antenna," said Greg Peters, vice president and general manager, Aerospace, Defense, Government Solutions Group, Keysight Technologies. "By measuring the matching characteristics of a trial radar antenna, ESA and Airbus (EADSY) engineers can correlate design simulation with actual test data."
GD

Hot Stocks

11:01 EDT General Dynamics awarded U.S. Army mission training support contract - General Dynamics Information Technology, a business unit of General Dynamics, was awarded the Mission Training Complex Capabilities Support contract by the U.S. Army Contracting Command. The multiple award, indefinite delivery, indefinite quantity contract has a ceiling value of approximately $975M with a five year ordering period. Work under the contract will consist of simulation and training support including live, virtual, constructive and first-person gaming exercises. Additional support will include technical, logistical and administrative services for designated mission training complexes.
BDRBF

Hot Stocks

10:58 EDT Bombardier, CemAir sign order for two new Q400 aircraft - Bombardier Commercial Aircraft announced today that CemAir of South Africa has concluded a firm purchase agreement for two new Q400 turboprops, and has also signed the lease of a used Q400 aircraft that was delivered this month, paving the way for the new aircraft to be delivered afterwards. The letter of Intent from CemAir, which was signed on June 21 at the 2017 Paris Air Show, has now been converted into a firm order. Based on the list price of the Q400 aircraft, the firm order is valued at approximately $66M.
TST

Hot Stocks

10:43 EDT TheStreet's BoardEx announces partnership with Dealogic - BoardEx, a business unit of TheStreet, announced a partnership with financial platform company Dealogic to distribute profiles of board members and senior executives. "This is the first step in a strategic partnership between BoardEx and Dealogic, bringing access to more than 1 million senior executive and director profiles, while further expanding the BoardEx brand within the investment banking sector. We look forward to future innovations together," said Jeff Davis, President of BoardEx.
CMG

Hot Stocks

10:18 EDT Chipotle, in search of new CEO, says founder Ells to focus on 'innovation' - Shares of Chipotle Mexican Grill (CMG) jumped in morning trading after the company announced it had begun to search for a new chief executive officer. Once the search is compete, Chipotle founder Steve Ells said he will focus primarily on innovation. Chipotle has faced several foodborne illness outbreaks since 2015. CEO SEARCH: Chipotle founder and current chairman and CEO Steve Ells will step down as CEO and transition to the role of executive chairman, the company said on Wednesday. The restaurant chain's board has formed a search committee to help find a new chief, Chipotle said. Directors Robin Hickenlooper and Ali Namvar, as well as Ells, are on the committee, the company noted, adding that recruitment firm Spencer Stuart will also assist in the search. In a statement, Ells commented that "It is clear that we need to move faster to make improvements," and "bringing in a new CEO is the right thing to do for all our stakeholders." Ells said the transition will allow him to focus on his strengths, "which include bringing innovation to the way we source and prepare our food." Chipotle lead independent director Neil Flanzraich commented that "Steve made the decision, and the Board agreed, that now is the right time to identify a new CEO who can reinvigorate the brand and help the company achieve its potential. We are committed to recruiting a world-class CEO for this incredible opportunity." WHAT'S NOTABLE: Chipotle has struggled to regain customers following numerous outbreaks of foodborne illnesses since 2015, including norovirus, salmonella and E.coli. Earlier this month, Jeremy Jordan, one of the stars of the television show "Supergirl," blamed the burrito chain for an illness that hospitalized him. Chipotle responded to Jordan's claims, saying "We take all claims seriously, but at this time we can't confirm any link to Chipotle." Chipotle said last month that its third quarter performance was hurt by a data security breach, Hurricanes Harvey and Irma and high prices of avocados. ANALYST COMMENTARY: William Blair analyst Sharon Zackfia downgraded Chipotle Mexican Grill to Market Perform from Outperform following the CEO search news, saying that while a new chief may accelerate the company's turnaround longer term, the move likely signals that Chipotle's trends remain under pressure and creates more near-term uncertainty. Stephens analyst Will Slabaugh, who has an Equal Weight rating and $300 price target on Chipotle shares, said the change will present an opportunity for positive change but also adds an element of risk to the proposed 5% price increase that he thinks is already being factored into most estimates in the consensus view. SunTrust analyst Jake Bartlett believes a change in leadership will be welcomed by investors, as the news is positive for both Chipotle's turnaround efforts and the stock. PRICE ACTION: Chipotle is up 4% to $297.66 in morning trading, though shares are still down about 21% year-to-date.
NURO

Hot Stocks

10:10 EDT NeuroMetrix announces issuance of new U.S. patent for Quell technology - NeuroMetrix announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,827,420. The patent covers novel technology that enhances Quell device usability by improving performance for users that maintain an active lifestyle.
OA NOC

Hot Stocks

10:09 EDT Orbital ATK shareholders approve acquisition by Northrop Grumman - Orbital ATK (OA) announced that its stockholders overwhelmingly approved the merger agreement providing for the proposed acquisition of Orbital ATK by Northrop Grumman (NOC) at a special meeting of stockholders held on November 29, 2017. Holders of more than 99% of Orbital ATK's common stock present at the meeting or represented by proxy voted in favor of approving and adopting the merger agreement, which represented approximately 79% of the total number of outstanding shares of Orbital ATK's common stock as of the October 10, 2017 record date for the special meeting. The company expects the transaction to close in the first half of 2018, pending receipt of regulatory approvals.
VIA VIAB

Hot Stocks

10:07 EDT Viacom appoints Joe Tolosa as chief transformation officer - Viacom announced it has appointed Jose Tolosa as chief transformation officer, effective immediately. Tolosa will report to Viacom president and CEO Bob Bakish. In this newly created role, Tolosa will oversee a team responsible for guiding Viacom's transformation agenda, and developing and executing initiatives that support and accelerate the strategic priorities set out as part of the company's Q4 and FY17 earnings results. Previously, Tolosa served as COO of Viacom International Media Networks, where he worked closely with senior leadership to accelerate the company's international growth strategy, including extending its pay TV footprint in key growth markets and increasing opportunities for consumers to access content across devices. In addition, VIMN today announced the appointment of Melody Tan as its new COO, succeeding Tolosa. Previously, Tan served as EVP, programming, strategy & operations for MTV, VH1 and Logo in the U.S.
KANG

Hot Stocks

09:35 EDT iKang Healthcare extends shareholder rights plan - iKang Healthcare announced that its Board of Directors has unanimously approved the extension of its Rights Agreement, presently scheduled to expire on December 2, 2017, for another year. As the Rights Agreement was designed to ensure that all shareholders of the Company receive fair and equal treatment in the event that an unsolicited attempt is made to acquire the Company outside of the process led by a special committee of independent directors, the Board of Directors and the special committee have determined that it is advisable and in the best interests of the Company and its shareholders to extend the Rights Agreement for an additional year, as the special committee continues to consider and evaluate the proposal submitted by Yunfeng Capital to acquire the Company.
SNAP

Hot Stocks

09:33 EDT Snap: New Snapchat is organized around relationships, personalized
SNAP

Hot Stocks

09:32 EDT Snap: New Snapchat separates social from the media
WHR

Hot Stocks

09:32 EDT Whirlpool completes expansion of manufacturing facility in Argentina - Whirlpool Corporation announced the completion of its manufacturing facility expansion in La Tablada city, located in Buenos Aires Province, Argentina. The development is part of a more than $20M dollar investment plan, which began last year when the facility started manufacturing ranges. The facility will now also manufacture front load washing machines with Sense Inverter technology. This investment will result in the addition of approximately one hundred new and three hundred indirect jobs. This facility represents the completion of a two-year project to allow the company to bring its global platform and new innovation to this important market, and to customize those innovations to meet the needs of consumers in this region.
SNAP

Hot Stocks

09:32 EDT Snap introduces 'new and improved' Snapchat - Snap says: "Today we're announcing a new and improved Snapchat - organized around your relationships and personalized just for you! Until now, social media has always mixed photos and videos from your friends with content from publishers and creators. While blurring the lines between professional content creators and your friends has been an interesting Internet experiment, it has also produced some strange side-effects (like fake news) and made us feel like we have to perform for our friends rather than just express ourselves. The new Snapchat separates the social from the media. This means that the Chats and Stories from your friends are on the left side of Snapchat, and the Stories from publishers, creators, and the community are on the right. We've also invented something new to make Snapchat feel even more personal: the dynamic Friends page. The new Friends page to the left of the camera displays your friends based on the way you communicate with them. You can think of it as a more sophisticated Best Friends algorithm that makes it easier to find the friends you want to talk to, when you want to talk to them. The new Discover page to the right of the camera includes Stories from publishers, creators, and the community. Your subscriptions live at the top, followed by other Stories you might be interested in watching. Over time, Discover will become uniquely personalized for you. And, as always, Snapchat opens to the Camera, making it the fastest way to share a moment with friends. Separating social from media has allowed us to build the best way to communicate with friends and the best way to watch great content - while addressing many of the problems that plague the Internet today." Reference Link
GLAD

Hot Stocks

09:29 EDT Gladstone Capital invests in GrayMatter - Gladstone Capital announced that it has completed a $9.5M subordinated debt investment in support of Hamilton Robinson Capital Partner's investment in GrayMatter, or GM. Headquartered outside Pittsburgh, PA, GM is a leading provider of operational technologies and Industrial IoT consulting services to the manufacturing, water and energy industries in North America. GM's holistic approach to OT includes a wide range of implementation services and software solutions designed to deliver high returns for machine-level automation and digitization projects to both optimize operations and ensure safe and reliable performance for their customers.
CMG...

Hot Stocks

09:18 EDT On The Fly: Pre-market Movers - HIGHER: Chipotle (CMG), up 4.8% after announcing it will begin a search for a new CEO... Melinta Therapeutics (MLNT), up 7.4% after announcing that it will acquire the infectious disease business from The Medicines Company (MDCO)... Domino's Pizza (DPZ), up 1.3% after being upgraded to Buy from Neutral at Nomura Instinet... Regal Entertainment (RGC), up 4.8% after confirming that it is currently engaged in discussions with Cineworld Group plc about a possible all-cash acquisition of Regal at a price of $23.00 per share... Nuance Communications (NUAN), up 5.6% after reporting quarterly results. LOWER: The Medicines Company is down 2.4% following the announcement that it will sell its infectious disease business to Melinta Therapeutics... Rex Energy (REXX), down 5.6% after reporting quarterly results... Autodesk (ADSK), down 11% after reporting quarterly results.
TYL

Hot Stocks

09:17 EDT Tyler Technologies acquires audio capture company Radio 10-33 - Tyler Technologies announced it has acquired audio and digital two-way radio communications technology and related assets from Radio 10-33, LLC. Tyler expects to deploy the acquired assets in future applications for recording E-911 transmissions. With this acquisition, Tyler is investing in enhanced capabilities that will provide added value to emergency communication centers, law enforcement, fire and EMS agencies for monitoring and responding to the regions they serve. During the coming months, Radio 10-33's technology and services offerings will be integrated into Tyler operations and branding.
BCOV KNCAY

Hot Stocks

09:11 EDT Konica Minolta selects Brightcove for enterprise video solution - Brightcove (BCOV) announced that Konica Minolta Business Solutions U.S.A (KNCAY) has selected Brightcove as its enterprise video solution. Konica Minolta is using Brightcove to power its internal training platform. Videos are created, personalized, and secured in a Single-Sign On environment. When employees access the platform, the catalogue of videos presented are personalized based on access rights and training curriculum.
AMZN...

Hot Stocks

09:07 EDT Expedia standardizes AWS machine learning tech across brands - Amazon Web Services (AMZN) announced that Expedia has gone all-in on AWS and is standardizing on AWS machine learning technologies to enhance travelers' booking experiences across its brands, including Expedia.com, Hotels.com, Expedia Affiliate Network, HomeAway, Egencia, and others. As part of a corporate-wide initiative to focus its engineering teams on innovation rather than hardware procurement and datacenter management, Expedia continues to move its 20 years' worth of core-business workloads, digital properties, mobile applications, and legacy platforms largely from owned datacenters to AWS and will migrate several databases from Microsoft (MSFT) SQL Server and Oracle to Amazon Aurora as part of that process. The travel industry giant chose AWS for its highly scalable infrastructure, unmatched breadth of cloud services, and proven operational expertise. In 2013, Expedia started leveraging AWS to speed up various large-scale projects, a move that set the stage for its future marketing agreements and, eventually, acquisitions. Expedia could not have integrated and completed one of its first acquisitions in just 91 working days without leveraging AWS for capacity and traffic management. In the last couple of years, Expedia accelerated its cloud migration efforts to move the vast majority of its workloads to AWS. Expedia used AWS's industry-leading services to build a scalable platform for faster application deployment and has been able to launch more than 4,000 cloud applications with a release velocity of 2,000 deployments a day, on average. In addition, the data science teams for Expedia Worldwide Engineering and Hotels.com are using AWS machine learning services to deploy a variety of modules that add intelligent capabilities to processes such as bidding on search engine marketing, providing post-booking recommendations to travelers, and matching great hotels with great prices for each booked trip.
WFC

Hot Stocks

09:05 EDT Wells Fargo names three new independent directors - The Board of Directors of Wells Fargo announced it has elected three new independent directors as part of its succession planning and refreshment process. The three new directors, each of whom will join the board on Jan. 1, 2018, are: Celeste A. Clark, former chief sustainability officer and global public policy and external relations officer of Kellogg Company, where she led Kellogg's global Corporate Communications, Public Affairs, Sustainability and Philanthropy functions. Theodore F. Craver, Jr., former chairman, president, and CEO of Edison International, one of the nation's largest electric utilities. Prior to joining Edison, Craver spent 23 years in banking and was corporate treasurer of First Interstate Bancorp, a Wells Fargo predecessor company. Maria R. Morris, who most recently was interim head of the U.S. Business and head of the Global Employee Benefits business of MetLife, Inc., where she previously was head of Technology and Operations. With today's announcement, the board has named six new directors in 2017 and a total of eight new independent directors since 2015. On Jan. 1, 2018, the average tenure of the board's directors will fall to slightly less than five years from 8.4 years at the company's 2017 annual meeting of shareholders. "The board's composition has changed significantly as it remains focused on being responsive to shareholders, enhancing oversight and creating value for shareholders," said Elizabeth A. "Betsy" Duke, vice chair, who becomes chair on Jan. 1, 2018. The election of Clark, Craver, and Morris as directors, which follows the board's election in 2017 of Karen B. Peetz, Juan A. Pujadas, and Ronald L. Sargent, will fill the vacancies created by the previously announced retirements of Cynthia H. Milligan, Stephen W. Sanger, and Susan G. Swenson at year-end 2017. As a result of those retirements and today's announcement, the board will have 16 members on Jan. 1, 2018.
AMZN DIS

Hot Stocks

09:04 EDT Disney selects Amazon as public cloud infrastructure provider - Amazon Web Services (AMZN) announced that The Walt Disney Company (DIS) has selected AWS as its preferred public cloud infrastructure provider. Disney will expand its use of AWS to migrate production workloads to the AWS Cloud. Disney already leverages AWS's industry-leading services for a wide variety of use cases, including websites and digital properties across all its brands, analytics, mobile, business applications, and machine learning. For more than eight years, AWS and Disney have collaborated to drive IT innovation. AWS has provided ongoing architectural best-practices support to enable Disney's planned migrations from on-premises to a cloud-based architecture. Disney's various segments, including Media Networks, Parks and Resorts, and The Walt Disney Studios, currently run business-critical workloads on AWS, driving optimal operational performance and customer experiences.
AMZN

Hot Stocks

09:03 EDT Amazon: Cyber Monday surpassed Prime Day for most products ordered worldwide
NLSN

Hot Stocks

09:03 EDT Nielsen launches its Marketing Cloud in APAC - Nielsen launched its Nielsen Marketing Cloud in APAC empowering its regional and global clients - including advertisers, agencies and media owners - to improve their advertising and content marketing effectiveness with an unrivaled combination of global audience data, technology and sales measurement solutions. Nielsen Marketing Cloud begins its APAC expansion in Hong Kong with enterprise client Television Broadcasts, or TVB, the largest TV broadcaster in Hong Kong and one of the largest Chinese content producers in the world. Nielsen Marketing Cloud anticipates additional APAC market launches in the near future.
AMZN

Hot Stocks

09:03 EDT NFL selects AWS as cloud and machine learning provider - Amazon Web Services announced that the National Football League as selected AWS's machine learning and data analytics services to boost the accuracy, speed, and insights provided by its Next Gen Stats platform, the NFL's player-tracking system. In choosing AWS to power Next Gen Stats, the NFL aims to develop new ways of visualizing the action on the field, uncovering deeper insights into the action on the field, and expanding the fan experience by offering a broader range of advanced statistics. In addition, AWS will become an Official Technology Provider of the NFL. Through the use of radio-frequency identification tags in player equipment and the football, Next Gen Stats captures a variety of real-time location, speed, and acceleration data. The data is analyzed on AWS and used to contextualize movement on the field for fans to see on NFL Media properties, game broadcasts, third-party digital platforms, and in-venue displays. The data is also leveraged by NFL clubs post game as part of their football operations on a weekly basis. The system creates a variety of unique player and team stats for every game such as a receiver's ability to get open and an offensive line's ability to protect the quarterback. By leveraging AWS's broad range of cloud-based machine learning capabilities, the NFL is looking to take its game-day stats to the next level so that fans and NFL Clubs can benefit from deeper insights.
AMZN

Hot Stocks

09:03 EDT Amazon confirms Cyber Monday was single biggest shopping day ever - Amazon announced that Cyber Monday was the single biggest shopping day worldwide in the company's history, and the biggest day ever for small businesses and entrepreneurs selling on Amazon. "Amazon customers shopped at record levels during the Turkey 5, ordering hundreds of millions of products from toys to fashion to electronics and Amazon devices," stated Jeff Wilke, CEO Worldwide Consumer. "Customers ordered nearly 140 million items from small businesses alone and this is just the beginning of the holiday season. We'll continue to offer incredible deals and a vast selection of unique products, with fast and free shipping options all season long, and every day." Throughout the Turkey 5, Amazon customers worldwide ordered at record levels: Customers ordered hundreds of millions of products on Amazon from Thanksgiving through Cyber Monday. Cyber Monday 2017 is now the single biggest shopping day in Amazon's history, surpassing Prime Day 2017. Amazon App orders on Cyber Monday 2017 increased more than 50 percent, worldwide year over year. On Cyber Monday, the best-selling item was the Echo Dot. With new lower prices on turkeys and Prime members receiving an even deeper discount this year, Whole Foods Market in the U.S. broke its all-time record of turkeys sold during the Thanksgiving season.
BTC...

Hot Stocks

09:03 EDT Bitcoin price rises above $11,000 - Bitcoin is up about 13% to $11,151.76 in U.S. dollar terms at time of writing, according to data from CoinDesk. Meanwhile, Bitcoin Investment Trust (GBTC) is up 11.25% in pre-market trading to $1,635.33.
QLYS

Hot Stocks

09:02 EDT Qualys to acquire certain assets of NetWatcher - Qualys announced that it has entered into an asset purchase agreement with NetWatcher, pursuant to which Qualys will acquire certain assets of NetWatcher in a cash transaction. This asset purchase provides significant domain expertise in building and delivering cybersecurity and real-time threat intelligence offerings. The NetWatcher service is expected to be fully integrated into the Qualys Cloud Platform in the next twelve months. The acquisition will incorporate NetWatcher's team into Qualys, including CEO Scott Suhy who is appointed Vice President of Strategic Alliances and Business Development for Qualys. Kenneth Shelton, CTO and founder of NetWatcher, will become Vice President of Engineering, Real-time Threat Correlation Platform at Qualys. Additionally, Qualys will continue to support existing NetWatcher customers and partners and sell its offerings and solutions worldwide. The asset acquisition is not material to Qualys financials.
CMCSA CMCSK

Hot Stocks

09:02 EDT Comcast, iHeartMedia partner to launch iHeartRadio on Xfinity X1 - Comcast and iHeartMedia announced a partnership that will make iHeartRadio available on Xfinity X1, giving people a new way to enjoy more than 1,000 radio stations from across the country - directly on their TV - with custom artist radio stations, playlists, podcasts and more iHeartRadio favorites coming soon. Beginning today and rolling out to capable X1 set-top boxes in the coming weeks, customers of both services will be able to use their voice remote to launch iHeartRadio or browse and select stations integrated throughout related sections of Xfinity On Demand.
DIS

Hot Stocks

08:55 EDT ESPN confirms plans to eliminate 150 jobs - ESPN President John Skipper shared this message with employees this morning. "Today we are informing approximately 150 people at ESPN that their jobs are being eliminated. We appreciate their contributions, and will assist them as much as possible in this difficult moment with severance, a 2017 bonus, the continuation of health benefits and outplacement services. They will also appreciate your support. The majority of the jobs eliminated are in studio production, digital content, and technology and they generally reflect decisions to do less in certain instances and re-direct resources. We will continue to invest in ways which will best position us to serve the modern sports fan and support the success of our business." Reference Link
TIF

Hot Stocks

08:53 EDT Tiffany: Top priority is to drive solid comp growth - Says top priority is to drive solid comp growth. While square footage is expected to increase modestly each year in the future, comp sales, ecommerce sales will be the primary drivers of growth. Sees gross margin roughly unchanged for FY vs. prior outlook of "modest" y/y increase.
TIF

Hot Stocks

08:39 EDT Tiffany: 'Strong' sales growth at competitors 'not acceptable in the long-term' - CEO Alessandro Bogliolo noted on Tiffany & Co's Q3 earnings conference call that while some of its competitors have posted stronger sales growth than the company, this "will not be acceptable in the long-term." The company noted that it saw a resumption of growth in Q3 in high, fine and solitaire jewelry.
SINO

Hot Stocks

08:32 EDT Sino-Global signs collaboration agreement with Sichuan Metals and Minerals - Sino-Global Shipping America announces the signing of a Strategic Collaboration Agreement with Sichuan Metals and Minerals, or SCMMC, a subsidiary of Sichuan Foreign Trade Group, a leading state-owned importer/exporter in the Sichuan province in China. Pursuant to the Strategic Collaboration Agreement, Sino-Global will serve as the exclusive purchasing agent and logistics service provider of sulfur products in the U.S. for SCMMC. This agreement will also mark the beginning of SCMMC's switch to containerization from the traditional bulk shipment of its products by exclusively using Sino-Global's innovative and cost-effective door to door container solution for the transport of its sulfur products. SCMMC has begun placing orders with Sino-Global for the purchase of approximately 2,400 metric ton or 120 containers of sulfur. Sino-Global expects to generate approximately $360,000 of revenue from these initial orders, with the Company expecting additional sales contracts to be finalized in the coming months.
ITI

Hot Stocks

08:32 EDT Iteris awarded Texas DOT IDIQ contract for smart transportation services - Iteris announced that it is one of 10 firms to be awarded the Texas Department of Transportation's Wave 4 Traffic Engineering indefinite delivery/indefinite quantity contract, a two-year commitment with a potential value of up to $2M. Task orders are anticipated in early 2018. Iteris' new IDIQ contract is assigned to the TxDOT San Antonio district, an area known for its smart transportation and traffic engineering innovations. The company anticipates task orders for traffic signal design and timing, as well as intelligent transportation systems planning and integration. In April of this year, Iteris was awarded an IDIQ contract from the TxDOT Houston district for traffic engineering and signal timing. That contract was also a two-year commitment with a potential value of up to $2M.
RYB

Hot Stocks

08:32 EDT RYB Education issues update on investigation into 'improper conduct' by staff - RYB Education issued an update following the local police authority's release of a follow-up report on November 28 regarding the investigation of the case initially described in RYB's press releases issued on November 24. According to the Follow-up Report, the police found maltreatment involving a former female teacher's use of sewing needles as a way to "discipline" children during post-lunch naptime at the RYB-operated kindergarten in violation of law. The police reported that no evidence has been found indicating further misconduct and that additional claims had been fabricated. Safety of the students is the highest priority of the Company. RYB is deeply saddened to learn about the latest findings in the Follow-up Report. The Company also understands that there have been additional parent complaints regarding other RYB-branded kindergartens and will continue to cooperate fully with the police and other authorities in this matter. The Company remains steadfast in its commitment to ensuring the well-being of all the students and is in the process of implementing a comprehensive self-inspection across all RYB teaching facilities.
ZGNX

Hot Stocks

08:25 EDT Zogenix initiates Phase 3 trial of ZX008 - Zogenix announced that the first child has enrolled in the Phase 3 clinical trial for the company's lead investigational therapy, ZX008, as an adjunctive treatment of seizures associated with Lennox-Gastaut syndrome, or LGS. The Phase 3 multicenter, global LGS trial is divided in two parts. Part 1 is a double-blind, placebo-controlled investigation to assess the safety, tolerability and efficacy of ZX008, low-dose fenfluramine, when added to a patient's current anti-epileptic therapy. The trial will include two dose levels of ZX008, as well as placebo. After establishing baseline seizure frequency for 4 weeks, randomized patients will be titrated to their dose over a 2-week titration period, followed by a 12-week fixed dose maintenance period. Zogenix is targeting a total of 225 patients in the trial. The primary endpoint of the clinical trial is change in the number of seizures that result in drops between baseline and the combined titration and maintenance periods at the 0.8 mg/kg/day dose. The key secondary endpoints include change in the number of seizures that result in drops between baseline and the combined titration and maintenance periods at the 0.2 mg/kg/day dose, and the proportion of patients achieving a 50 percent reduction in drop seizures. Part 2 of the clinical trial will be a 12-month open-label extension to evaluate the long-term safety, tolerability and effectiveness of ZX008.
PFPT

Hot Stocks

08:24 EDT Proofpoint agrees to acquire Weblife.io for $60M - Proofpoint has entered into a definitive agreement to acquire Weblife.io. The agreement is subject to customary closing conditions and is expected to close in the fourth quarter of 2017. The acquisition is expected to have no material impact to billings, revenue, net income and free cash flow for both Q4 2017 and FY 2018 as provided on October 19, 2017, and updated on November 21, 2017.
TEUM

Hot Stocks

08:18 EDT Pareteum regains compliance with NYSE American listing standards - Pareteum announced receipt, on November 27, of notification from NYSE Regulation that the Company has regained compliance with Section 1003 of the NYSE American's Company Guide relating to minimum shareholders' equity. The Company previously received notification from the NYSE American citing failure to comply with the minimum shareholders' equity and minimum stock price standards. With this latest notice, Pareteum has now cured the previously cited deficiencies and is in compliance with the NYSE American's continued listing standards. Effective November 29, 2017, the ".bc" designation, signifying non-compliance with NYSE American listing standards will be removed from the Company's trading symbol.
W

Hot Stocks

08:18 EDT Wayfair sees 53% increase in direct retail sales for five-day holiday weekend - Wayfair reported a 53% increase year over year in direct retail gross sales, defined as dollars of order intake, for the five-day peak shopping period of Thanksgiving Day through Cyber Monday. The company experienced its strongest sales day ever on Cyber Monday with peak order volume between 9 p.m. and 12 a.m. ET. Total orders from repeat customers accounted for 63% of holiday orders. On Cyber Monday, Wayfair customers purchased a sofa every 13 seconds, a mattress every eight seconds and a rug every two seconds.
INO

Hot Stocks

08:17 EDT Inovio: VGX-3100 data showed immune correlates, signatures predictive of success - Inovio Pharmaceuticals announced that post-hoc analysis of data generated from its phase 2b trial of VGX-3100 identified immune correlates and biomarker signatures predictive of treatment success. VGX-3100, Inovio's lead product now in a pivotal phase 3 trial, would be the first non-surgical treatment for HPV-associated high grade cervical dysplasia which frequently progresses to cancer. Details of the new biomarker and immunologic data are highlighted in the peer-reviewed journal Clinical Cancer Research in the article, "Clinical and Immunologic Biomarkers for Histologic Regression of High-grade Cervical Dysplasia and Clearance of HPV-16 and HPV-18 after Immunotherapy," by Inovio and its academic collaborators. In this paper, Inovio has identified biomarker signatures which predicted success of VGX-3100 treatment as early as two weeks after the completion of treatment which was a full 22 weeks prior to the formal efficacy assessment. The company believes these biomarkers will aid physicians in guiding patient care during VGX-3100 treatment, and is pursuing the confirmation of these predictions in its phase 3 program. Inovio is also researching pre-treatment biomarkers which could identify patients most likely to respond to treatment with VGX-3100, increasing absolute efficacy of the product. Dr. J. Joseph Kim, President and CEO, said: "Inovio will transform the treatment of HPV-associated disease with the first immunotherapies to treat both pre-cancer and cancer caused by HPV which infects more than 70% of sexually active adults. Today's advancement in discovering a successful treatment biomarker moves us closer to that goal."
SEED

Hot Stocks

08:16 EDT Origin Agritech enters into license agreement with KWS - Origin Agritech announced that the company has entered into a commercial biotechnology trait and corn germplasm license agreement with KWS SAAT SE, or KWS, one of the world's leading plant breeding and seed companies. This agreement facilitates KWS' entry into China's corn biotechnology trait and expanded seed market. Under the agreement, Origin will combine insect resistance and herbicide tolerance traits co-developed by the Chinese Academy of Agriculture Sciences and Origin Agritech into KWS corn inbred lines. Biotech-enhanced corn is planned to be deployed upon Chinese commercial and regulatory approval. Future biotech enhanced versions of these products will also be made available to KWS to serve Chinese farmers.
SPI

Hot Stocks

08:12 EDT SPI Energy regains compliance with Nasdaq - SPI Energy announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market Inc. stating that the company has regained compliance with the Nasdaq Listing Rule 5450(a)(1) with respect to the bid price of the company's ordinary shares. As stated in the letter, Staff has determined that for at least the last 10 consecutive business days, from November 8, to November 24, the closing bid price of the company's ordinary shares has been at $1.00 per share or greater.
AGLE

Hot Stocks

08:10 EDT Aeglea doses first pediatric patient in pegzilarginase Phase 1/2 clinical trial - Aeglea BioTherapeutics announced dosing of the first pediatric patient in its ongoing Phase 1/2 clinical trial in patients with Arginase 1 Deficiency and provided a regulatory update on its pegzilarginase rare disease program. Aeglea reached agreement with the FDA that available data supports the prospect for benefit in pediatric patients and amended its Phase 1/2 trial protocol to include pediatric dosing tiered by age beginning with patients aged 14 to 17, and continuing with patients aged 2 to 13.
CMG

Hot Stocks

08:09 EDT Chipotle trading resumes
RUN

Hot Stocks

08:07 EDT Sunrun appoints Evelyn Huang Chief Customer Experience Officer - Sunrun announced it has expanded its management team to meet the needs of its growing customers. Evelyn Huang, an expert in customer experience, product and design strategy, has joined Sunrun as Chief Customer Experience Officer. Huang will report directly to Sunrun CEO Lynn Jurich and will lead the company's brand, marketing, products, customer realization and corporate communications teams.
PLX

Hot Stocks

08:05 EDT Protalix completes enrollment in OPRX-106 phase II clinical trial - Protalix BioTherapeutics announced the completion of enrollment in the company's phase II clinical trial evaluating OPRX-106, the company's oral antiTNF product candidate, in patients with ulcerative colitis, or UC. OPRX-106 is the company's proprietary plant cell-expressed recombinant human tumor necrosis factor receptor II fused to an IgG1 Fc domain. When administered orally and while passing through the digestive tract, the plant cells function as a natural delivery capsule, having the unique attribute of a cellulose cell wall, which makes them resistant to degradation compared to proteins produced via mammalian cell expression systems. The company expects to report top-line results from this study in the first quarter of 2018.
EQIX AMZN

Hot Stocks

08:04 EDT Equinix expands collaboration with Amazon Web Services - Equinix (EQIX) announced an expansion of its collaboration with Amazon Web Services (AMZN) with the extension of direct, private connectivity to the AWS Direct Connect service to four additional Equinix International Business Exchange data centers in North America and Europe. The move advances the Equinix and AWS collaboration that enables businesses to connect their owned and managed infrastructure directly to AWS via a private connection, which helps customers reduce costs, improve performance and achieve a more consistent network experience. Effective immediately, AWS Direct Connect will be available to customers in Equinix IBX data centers in Helsinki, Madrid, Manchester and Toronto, bringing the total number of Equinix metros offering AWS Direct Connect to 21, globally. Customers can connect to AWS Direct Connect at all available speeds via Equinix Cloud Exchange, cross connects or Equinix-provided metro connectivity options. Additionally, with the recently announced AWS Direct Connect Gateway, Equinix customers can also access multiple AWS regions with a single conection to AWS Direct Connect.
SPLK AMZN

Hot Stocks

08:04 EDT Splunk announces new integrations with Amazon Kinesis Firehouse, GuardDuty - Splunk (SPLK) announced new product integrations with Amazon Web Services (AMZN) that span IT, Security, Big Data and IoT use cases. Integrations with Amazon Kinesis Firehose, the first partner integration of its kind, and Amazon GuardDuty deliver Splunk's commitment to continuous innovation for customers. Customers are already leveraging the Amazon Kinesis Firehose integration to stream AWS data into Splunk solutions to manage and enhance their IT and security environments.
CMG

Hot Stocks

08:04 EDT Chipotle's Ells: Bringing in a new CEO 'the right thing to do for stakeholders'
CMG

Hot Stocks

08:03 EDT Chipotle's Steve Ells: 'Clear we need to move faster to make improvements'
AIR

Hot Stocks

08:03 EDT AAR subsidiary awarded first order from U.S. Department of State - AAR announced that its subsidiary, AAR Airlift Group, received its first work order from the U.S. Department of State and has begun work on the transition phase of the Worldwide Aviation Support Services, or WASS, contract. This follows the October 31, decision by the U.S. Court of Federal Claims, or COFC, upholding the State Department's September 1, 2016 award of the contract.
BLUE

Hot Stocks

08:03 EDT bluebird bio acquires manufacturing facility in North Carolina - bluebird bio (BLUE) announced it has acquired a 125,000-square foot manufacturing facility in Durham, North Carolina. Once construction and validation is complete, the site will produce lentiviral vector for the company's gene and cell therapies, including: Lenti-D for the treatment of cerebral adrenoleukodystrophy; LentiGlobin for the treatment of transfusion-dependent beta-thalassemia and severe sickle cell disease; and bb2121 and bb21217 for the treatment of multiple myeloma. The company is making a significant investment in its manufacturing infrastructure as it advances multiple products into late-stage development and potential commercial launch. Expanding in-house expertise, creating an extensive manufacturing network, and increasing manufacturing capacity ensures that bluebird can deliver on the promise of these product candidates. In addition to the internal manufacturing capacity that this site will provide, bluebird bio also has now entered into multi-year agreements with three manufacturing partners in the United States and Europe: Brammer Bio, Novasep and MilliporeSigma, the Life Science business of Merck (MRK). Each of these partners is collaborating with bluebird bio on production of lentiviral vector across all programs.The initial North Carolina site build-out will allow for production of clinical and commercial supply of lentiviral vector, which is a critical component of the company's gene and cell therapies. The facility is large enough to accommodate significant potential future expansion, including the possibility of commercial drug product production.
CMG

Hot Stocks

08:03 EDT Chipotle: Steve Ells to become executive chairman upon CEO search completion
ALDX

Hot Stocks

08:03 EDT Aldeyra presents noninfectious anterior uveitis Phase 2 clinical trial data - Aldeyra Therapeutics presented new statistical analyses of the results of a randomized, multi-center, investigator-masked, comparator-controlled, parallel-group Phase 2 clinical trial of topical ocular reproxalap (formerly known as ADX-102), a first-in-class aldehyde sequestering agent, to the American Uveitis Society held at the American Academy of Ophthalmology 2017 Annual Meeting. The results of the analyses demonstrated formal statistical non-inferiority (p=0.036 after two weeks of therapy, p=0.048 after four weeks of therapy) of 0.5% reproxalap ophthalmic solution to Pred Forte, a topical ocular corticosteroid, in reducing anterior chamber inflammatory cell count, the standard noninfectious anterior uveitis clinical endpoint. The combination of reproxalap and low-frequency (twice-daily) Pred Forte administration was also statistically non-inferior to Pred Forte monotherapy (four-times-daily). Dr. John Sheppard, an internationally recognized expert in ocular inflammation, gave the presentation, which is available on the investor relations page of the Aldeyra Therapeutics.
CMG

Hot Stocks

08:02 EDT Chipotle forms search committee to identify new CEO - Chipotle Mexican Grill announced that Steve Ells, chairman and CEO -- and the founder of the company in 1993 -- will become executive chairman following the completion of a search to identify a new CEO. The Board has formed a search committee comprised of Directors Robin Hickenlooper and Ali Namvar, as well as Ells, to identify a new leader with demonstrated turnaround expertise to help address the challenges facing the company, improve execution, build customer trust, and drive sales. Ells said, "Simply put, we need to execute better to ensure our future success. The Board and I are committed to bringing in an experienced leader with a passion for driving excellence across every aspect of our business, including the customer experience, operations, marketing, technology, food safety, and training. Bringing in a new CEO is the right thing to do for all our stakeholders. It will allow me to focus on my strengths, which include bringing innovation to the way we source and prepare our food. It will ultimately improve our ability to provide our guests with delicious food that is prepared with high quality ingredients that are raised responsibly and served in a way that is accessible to everyone. I am confident that this will allow us to deliver value for our shareholders, and provide rewarding opportunities for our employees. Chipotle has vast unrealized potential. As we work hard to restore our brand, I believe we can capitalize on opportunities, including in areas such as the digital experience, menu innovation, delivery, catering, and domestic and international expansion, to deliver significant growth."
SAR

Hot Stocks

08:02 EDT Saratoga Investment raises dividend to 49c from 48c - Saratoga Investment announced that its Board of Directors has declared an increased quarterly dividend of 49c per share for the fiscal quarter ended November 30 payable on December 27 to all stockholders of record at the close of business on December 15. It has continued to pay quarterly dividends regularly throughout FY18 including 48c per share for the quarter ended August 31.
CMG

Hot Stocks

08:02 EDT Chipotle begins search for new CEO
GPN AAPL

Hot Stocks

08:01 EDT Global Payments, CaixaBank bring Apple Pay to customers - Comercia Global Payments EP, S.L, a joint venture between U.S.-based Global Payments (GPN) and CaixaBank, announced that it now brings its customers Apple Pay (AAPL). Using the new CaixaBank Pay app users can now add their Caixabank cards to Apple Wallet and seamlessly use Apple Pay for purchases at any contactless enabled retail location.
CMG

Hot Stocks

07:39 EDT Chipotle trading halted, news pending
XGTI LDOS

Hot Stocks

07:34 EDT xG Technology awarded subcontract from Leidos - xG Technology announced that it has been awarded a subcontract from Leidos to provide interference mitigation solutions and simulation models under a Defense Advanced Research Projects Agency, or DARPA, shared spectrum research program. The program seeks to develop spectrum sharing technologies that enable access and mitigate the impact of spectrum congestion.
MLNT

Hot Stocks

07:33 EDT Melinta Therapeutics Inc trading resumes
IDRA

Hot Stocks

07:32 EDT Idera Pharmaceuticals granted Fast Track designation for IMO-2125 by FDA - Idera Pharmaceuticals announced that the FDA has granted Fast Track designation for the company's lead development candidate IMO-2125 in combination with Ipilimumab for the treatment of anti-PD-1 refractory metastatic melanoma in combination with ipilimumab therapy. FDA's Fast Track program is designed to expedite the development and review of drugs and biologics to treat serious or life-threatening conditions with non-clinical or clinical data demonstrating the potential to address unmet medical needs. Such drugs may qualify for Fast Track designation.
EGL

Hot Stocks

07:31 EDT Engility secures $20M task order with Naval Air Warfare Center - Engility secured a $20M task order with the Naval Air Warfare Center, Aircraft Division to maintain the AN/SPN-43 Radar and associated air traffic control systems and develop upgrades that will extend the lifetime of the systems. Engility engineers will support the NAWCAD ATC system used on all aircraft carriers and amphibious assault ships. This contract leverages Engility's full-life-cycle-development expertise, which includes engineering, design, fabrication and system architecture services. The company will also install and integrate system components for testing and analysis. The contract continues a chain of ATC-related successes in 2017: Members of Engility's NASA team received the agency's Software of the Year award for work on ATC enhancements; and the company continues to win awards with the Department of Transportation. The cost-plus-fixed-fee, third quarter win, awarded under the 4.11.7 Multiple Award Contract, represents new work and has a base year with three option years.
CMCSA CMCSK

Hot Stocks

07:29 EDT Trump: 'When will top execs at NBC & Comcast be fired for putting out Fake News' - President Donald Trump tweeted, "Wow, Matt Lauer was just fired from NBC for 'inappropriate sexual behavior in the workplace.' But when will the top executives at NBC & Comcast be fired for putting out so much Fake News. Check out Andy Lack's past!" Reference Link
CMCSA CMCSK

Hot Stocks

07:18 EDT Andy Lack to staff: Lauer complaint 'clear violation of company standards' - Andy Lack, the chairman of NBC News, said in a statement that his "highest priority is to create a workplace environment where everyone feels safe and protected and to ensure that any actions that run counter to our core values are met with consequences, no matter who the offender."
CMCSA CMCSK

Hot Stocks

07:13 EDT NBC News terminates Matt Lauer for inappropriate sexual behavior - The Today Show tweeted that "Matt Lauer has been terminated from NBC News. On Monday night, we received a detailed complaint from a colleague about inappropriate sexual behavior in the workplace by Matt Lauer. As a result, we've decided to terminate his employment." Reference Link
MLNT MDCO

Hot Stocks

07:12 EDT Melinta to acquire infectious disease business from The Medicines Co. - Melinta Therapeutics (MLNT) announced that Melinta and The Medicines Company (MDCO) have entered into an agreement pursuant to which Melinta will acquire the infectious disease business from The Medicines Company. This includes three marketed products: recently approved and launched Vabomere, and established commercial products Orbactiv and Minocin IV. The acquisition was unanimously approved by Melinta's board and is expected to close in Q1 of 2018, subject to satisfaction of customary closing conditions, including Melinta stockholder approval. The acquisition includes the purchase of global rights for three marketed products and the business supporting those products. Recently launched Vabomere is a novel fixed-dose combination agent comprising vaborbactam, a beta-lactamase inhibitor, and meropenem, the leading carbapenem. Vabomere was approved by the FDA after priority review in August 2017 and is indicated for the treatment of adult patients with complicated urinary tract infections, or cUTI, including pyelonephritis caused by designated susceptible Enterobacteriaceae. Vabomere's Phase 3 TANGO II trial, a randomized trial comparing Vabomere to the best available therapy for the treatment of serious carbapenem-resistant Enterobacteriaceae, or CRE, infections, was stopped early by an Independent Data and Safety Monitoring Board following a risk-benefit analysis of available data which was in favor of Vabomere. Vabomere's Marketing Authorization Application is currently under regulatory review by the European Medicines Agency for cUTI. Orbactiv is an injectable product approved by the FDA and EMA for the treatment of adults with acute bacterial skin and skin structure infections, or ABSSSI, caused by susceptible designated gram-positive bacteria including methicillin-resistant Staphylococcus aureus, or MRSA. Minocin IV, an injectable product, is a tetracycline derivative approved in the U.S. for the treatment of infections due to susceptible strains of several important designated gram-positive and gram-negative pathogens, including infections due to Acinetobacter species, which typically occur in hospitalized patients. Under the terms of the acquisition agreement, the purchase price consists of a payment by Melinta to The Medicines Company of $165M in cash and the issuance to The Medicines Company of a number of shares of Melinta common stock equal to $50M, divided by 90% of the volume weighted average price for the trailing 10 trading day period ending 3 trading days prior to closing; a payment by Melinta to The Medicines Company of $25M following each of the twelve and eighteen month anniversaries of the closing date, and payment by Melinta to The Medicines Company of certain royalty payments, based on tiered net sales of the acquired products in certain jurisdictions. Funding for this acquisition will be provided through both debt and equity. In conjunction with the closing of the acquisition, Melinta will enter into a Loan and Security Agreement with Deerfield Management Company, L.P. Deerfield and certain funds managed by Deerfield will initially provide a total of $190M in debt and equity financing. An additional $50M of debt is available to Melinta within 24 months of the acquisition close upon the achievement of certain sales thresholds. In addition to the funding from Deerfield, certain investors are committed to make a $30M equity investment at closing. These funds will be used to fund the initial cash acquisition price of $165M and to retire existing company debt of $40M. Additional information on the acquisition and related financing will be contained in the proxy statement related to the proposed transactions. Melinta stockholders holding approximately 52% of the outstanding common stock have executed voting agreements agreeing to vote their shares in favor of the transaction.
PSTI

Hot Stocks

07:11 EDT Pluristem announces peer-reviewed article on Cytotherapy - Pluristem Therapeutics announced the publication of a peer-reviewed article in Cytotherapy, the official journal of the International Society for Cellular Therapy, titled, "Placenta-Derived PLX-PAD Mesenchymal-Like Stromal Cells are Efficacious in Rescuing Blood Flow in Hind Limb Ischemia Mouse Model by a Dose- and Site-Dependent Mechanism of Action, or MOA." The article is based on the Company's preclinical findings and will be published in the December 2017 issue of Cytotherapy. The study utilized a mouse model of hind limb ischemia, or HLI, to study the efcacy and MOA of PLX-PAD cells in the treatment of peripheral artery disease, or PAD. Pluristem is currently conducting a global, pivotal Phase III study in critical limb ischemi, CLI, and is expecting clinical data from its Phase II study in intermittent claudication, IC. Both are forms of peripheral artery disease. In both conditions, blood supply to the legs is obstructed, leading to impaired blood ow and tissue ischemia.
PX

Hot Stocks

07:09 EDT Linde says 92% of shares tendered by end of exchange period - Linde plc announced that 92% of the ordinary shares of Linde AG entitled to voting rights were tendered by the end of the additional acceptance period of Linde plc's exchange offer on November 24, 2017. The tender process has been completed and no further Linde AG shares can be tendered in the exchange offer. The business combination remains subject to the receipt of certain antitrust and other regulatory approvals and is expected to be completed in the second half of 2018. Aldo Belloni, CEO of Linde AG, said: "We are appreciative for our shareholders' confidence in this opportunity to create a leading company in our industry. We are moving forward with the regulatory review process at full speed and with our most focused attention." If the business combination is completed, Linde plc could initiate a merger-related squeeze-out with respect to Linde AG under German law because the acceptance level in the exchange offer has reached 90%. However, no decision with respect to such squeeze-out has yet been made.
AVIR

Hot Stocks

07:07 EDT Aviragen completes enrollment in teslexivir Phase 2 clinical trial - Aviragen Therapeutics announced the completion of patient enrollment in its Phase 2 CT4 clinical trial evaluating teslexivir for the treatment of condyloma. The company expects to report top-line data from this trial in the second quarter of 2018. CT4 is a Phase 2 double-blind, randomized, multi-center, placebo-controlled trial designed to evaluate the safety, tolerability and efficacy of teslexivir 5% gel in male and female patients with condyloma, or anogenital warts.
RXII

Hot Stocks

07:06 EDT RXi Pharmaceuticals announces 'positive' results with RXI-231 in testing program - RXi Pharmaceuticals announced the results of a consumer/functional testing program with RXI-231, a cosmetic ingredient based on sd-rxRNA that targets tyrosinase. The cosmetic product is a gel formulation designed to aid in the reduction of pigmentation and thereby improving skin appearance. The results from the completed consumer testing program, in combination with previously announced preclinical data on melanin content in cultured melanocytes and 3-dimensional reconstituted human skin models, show that RXI-231 has the potential to reduce skin pigmentation induced by UV exposure in vivo.
MDCO MLNT

Hot Stocks

07:06 EDT The Medicines Co. to sell infectious disease unit to Melinta Therapeutics - The Medicines Company (MDCO) announced that it has entered into a definitive agreement to sell its infectious disease business unit to Melinta Therapeutics (MLNT) for $270M in upfront consideration and guaranteed payments, $215M of guaranteed cash and $55M of Melinta common stock, tiered royalty payments of 5% to 25% on worldwide net sales of Vabomere, Orbactiv and Minocin IV, and the assumption by Melinta of all royalty, milestone and other payment obligations relating to those products. The transaction is expected to close in the first quarter of 2018, subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the receipt of Melinta shareholder approval for the issuance of Melinta common stock to the Company and in connection with its financing for the transaction. Holders of a majority of Melinta's outstanding common stock have entered into binding agreements to vote in favor of the transaction. Cadwalader, Wickersham & Taft LLP is serving as legal counsel, and Citi is acting as financial advisor, to the Company in connection with the transaction. Concurrent with the execution of the Purchase and Sale Agreement, The Medicines Company received a binding commitment from an affiliate of Deerfield Management Company, which has also committed to provide financing to Melinta in connection with the transaction, to provide a $100M credit facility for working capital purposes and other general corporate purposes. Loans under the credit facility will bear interest at a rate of 5% per annum and, if drawn upon, will mature on the earlier of the closing of the Melinta transaction or one year. The Deerfield facility is subject to the execution of definitive loan documents.
REXR

Hot Stocks

07:06 EDT Rexford Industrial acquires four industrial properties for $69.6M - Rexford Industrial Realty announced the acquisition of four industrial properties for approximately $69.6M. The acquisitions were funded using cash on hand, draws on the Company's line of credit and proceeds from two dispositions totaling $30.6M. The Company acquired 687 Eucalyptus Avenue, located in Inglewood in the Los Angeles - West Los Angeles/South Bay submarket for $53.9M, or $376 per square foot. Also in the Los Angeles - South Bay submarket, the Company acquired a two-property portfolio consisting of 15401 S. Figueroa Street and 13225 S. Western Avenue located in Gardena for $6.7M, or $112 per square foot. 15401 S. The Company acquired an improved land site at 8542 Slauson Avenue, located in Pico Rivera in the Los Angeles - Central submarket for $9.0M, or approximately $49 per square foot of land. The Company sold 12345 First American Way in the Central San Diego submarket for approximately $7.6M, or $190 per square foot.
KKR

Hot Stocks

07:05 EDT KKR closes $1.45B health care strategic growth fund - KKR announced the final closing of KKR Health Care Strategic Growth Fund, a $1.45B fund dedicated to health care growth equity investment opportunities in the Americas. KKR will be investing more than $265M of capital in the Fund alongside external investors through KKR's balance sheet and employee commitments.
CUB

Hot Stocks

07:04 EDT Cubic awarded $61M contract by U.S. Army - Cubic announced that its Cubic Global Defense, or CGD, business division was awarded a contract worth more than $61M from the U.S. Army Contracting Command to support rotational and pre-deployment training exercises at the U.S. Army's Joint Readiness Training Center, or JRTC. The awarded amount is for the combined one-year phase-in and base period with four additional option years. Cubic will perform work in Fort Polk, Louisiana with an estimated completion date of November 24, 2022.
PCRX

Hot Stocks

07:03 EDT Pacira collaborates with Cancer Treatment Centers of America - Cancer Treatment Centers of America and Pacira Pharmaceuticals announced a new collaboration dedicated to reducing the risk of opioid dependence among cancer patients. The goal of the Opioid Risk Reduction Initiative-an educational effort focused on responsible use and increased awareness of opioid alternatives-is to improve the cancer patient experience through expanded pain management options.
RGS PII

Hot Stocks

07:02 EDT Regis appoints Amanda Rusin as general counsel - Regis Corporation (RGS) announced that the Board has appointed Amanda Rusin as SVP, general counsel, and secretary effective January 2018. Rusin succeeds Eric Bakken, who, as previously announced, was appointed president of franchise of Regis in April. Rusin currently serves as Assistant General Counsel at Polaris Industries (PII), a global powersports company.
REGN

Hot Stocks

07:02 EDT Regeneron and Decibel to collaborate in hearing therapeutics - Regeneron Pharmaceuticals and Decibel Therapeutics announced a collaboration to discover and develop new potential therapeutics to protect, repair, and restore hearing. Decibel is establishing a leadership position in hearing therapeutics by building the world's first comprehensive, integrated drug discovery, translational research, and drug development platform for hearing loss and tinnitus. Regeneron will provide Decibel with broad access to its proprietary suite of technologies to support Decibel's goal of discovering important new medicines for hearing. Regeneron will also directly participate in and provide financial support for Decibel's research and development efforts, both through R&D funding payments and a strategic equity investment in Decibel. Decibel retains worldwide development and commercialization rights to any products discovered in the collaboration and will pay Regeneron tiered royalties based on net sales. Further financial terms were not disclosed
CAPR

Hot Stocks

07:02 EDT Capricor Therapeutics announces FDA clearance of IND for CAP-1002 - Capricor Therapeutics announced that the U.S. FDA has cleared its Investigational New Drug application to conduct a new clinical trial of CAP-1002, its lead investigational therapy, in boys and young men in advanced stages of Duchenne muscular dystrophy, a fatal genetic disorder for which there are limited treatment options. This randomized, double-blind, placebo-controlled clinical trial will be called the HOPE-2 Trial and is designed to evaluate the safety and efficacy of intravenous, repeat doses of CAP-1002 in boys and young men whose ability to walk has been seriously impaired by the loss of muscle function that occurs as Duchenne muscular dystrophy progresses. The primary efficacy endpoint will be the relative change in the mid-level dimension of the Performance of the Upper Limb test from baseline to Month 12. The HOPE-2 Trial is expected to enroll approximately 84 patients and be conducted at 10-12 U.S. sites. Capricor believes that if the primary endpoint is reached, the HOPE-2 Trial could serve as a registration trial, meaning that its results could support the submission of a Biologics License Application to obtain marketing approval of CAP-1002. Capricor expects to initiate the HOPE-2 Trial in the first quarter of 2018. Capricor plans to apply for the Regenerative Medicine Advanced Therapy (RMAT) Designation for CAP-1002 based on updated guidance recently issued by the FDA. If granted, the RMAT Designation would be expected to facilitate CAP-1002's path to potential registration.
NRZ

Hot Stocks

06:58 EDT New Residential to acquire Shellpoint Partners for $190M - New Residential Investment announced that it has entered into definitive agreements to acquire Shellpoint Partners, a vertically integrated mortgage platform with established origination and servicing capabilities, for approximately $190M, subject to certain adjustments, plus potential additional consideration pursuant to a three-year earnout based on the performance of Shellpoint after closing. Shellpoint is an approved Fannie Mae and Freddie Mac seller and servicer and a Ginnie Mae issuer, with servicer ratings from S&P, Moody's and Fitch. The transactions have been approved by the board of directors of each company. Consummation of the Shellpoint acquisition is expected to occur in two stages. First, settlements on approximately $8B UPB of Fannie Mae & Freddie Mac Mortgage Servicing Rights. In the second stage of the acquisition, New Residential will acquire 100% of the outstanding equity interests of Shellpoint. The corporate acquisition is expected to close in the first half of 2018, subject to receipt of regulatory approvals and certain third party consents and satisfaction of certain other closing conditions.
CSGP

Hot Stocks

06:56 EDT CoStar Group discloses FTC request for additional information about acquisition - In a regulatory filing yesterday, CoStar Group disclosed that the company and Landmark Media Enterprises each received a request for additional information and documentary materials from the United States Federal Trade Commission with respect to the previously disclosed deal for the company's wholly owned subsidiary CRI to acquire all of the issued and outstanding shares of common stock of DE Holdings "The request for information from the FTC, commonly referred to as a "second request," is part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 . The second request extends the waiting period imposed by the HSR Act until 30 days after the parties have substantially complied with the second request unless that period is extended voluntarily by the parties or terminated sooner by the FTC. The Company intends to respond expeditiously to this request. The Company and Landmark have been working cooperatively with the FTC as it conducts its review of the proposed transaction, and will continue to do so through the completion of that review. The Company expects the Acquisition to close in the first half of 2018, subject to the expiration or termination of the applicable waiting period under the HSR Act and the satisfaction or waiver of all closing conditions," CoStar said.
TIF

Hot Stocks

06:51 EDT Tiffany: Net inventories at October 31 were 1% above the prior year period - Net inventories of $2.3B at October 31, 2017 were 1% above the prior year.
TIF

Hot Stocks

06:47 EDT Tiffany CEO says Q3 results 'marginally exceeded our expectations' - Alessandro Bogliolo, CEO, who joined Tiffany in October, said, "Tiffany is such an inspiring brand with an incredibly rich legacy, traditions of excellence in craftsmanship and design, and leadership in sustainability. I am very excited to be leading our team and enthusiastic about the tremendous opportunities we have to further develop our global business. These latest financial results marginally exceeded our expectations, but I believe that Tiffany has the medium to long-term potential to achieve meaningful comparable store sales growth and drive higher operating margins and earnings growth. Looking forward, we will increasingly capitalize on the strength of the TIFFANY & CO. brand with stronger organizational focus on innovation in product, digital, communication and the customer experience."
TIF

Hot Stocks

06:45 EDT Tiffany reports Q3 gross margin increased to 61.3% - Gross margin increased to 61.3% in the third quarter, from 61.0% in the prior year. Year-to-date gross margin increased to 61.9%, versus 61.4% in the prior year, primarily reflecting favorable product input costs partly offset by the negative effect of increased wholesale sales of diamonds.
TIF

Hot Stocks

06:45 EDT Tiffany reports net inventories at October 3 were 1% above the prior year period - Net inventories of $2.3B at October 31, 2017 were 1% above the prior year.
TIF

Hot Stocks

06:41 EDT Tiffany reports Q3 SSS down 1% - Reflecting sales growth in most regions, as well as increased sales in the Fashion Jewelry and the High, Fine & Solitaire Jewelry categories. On a constant-exchange-rate basis that excludes the effect of translating foreign-currency-denominated sales into U.S. dollars, worldwide net sales increased 3% and comparable store sales were equal to the prior year.
IDTI

Hot Stocks

06:37 EDT Integrated Device enters partnership with X-Microwave - Integrated Device Technology announced that it has partnered with X-Microwave, an industry leader in modular RF and microwave systems and tools, and innovator of the "Modular Building Block System", to deliver a complete solution for customers designing with IDT RF and microwave products. IDT's customers will now have access to our industry-best RF products coupled with complete design tools to address every phase of the development process from concept to prototype to production hardware.
QTRH

Hot Stocks

06:36 EDT Quarterhill subsidiary International Road Dynamics awarded $3.7M contract - Quarterhill announced that its wholly owned subsidiary, International Road Dynamics, or IRD, has been awarded a contract valued at more than $3.7M with the Idaho Transportation Department, or ITD, to supply and install a Mainline Electronic Screening System at the Sage Junction Port of Entry. This system will weigh and measure commercial vehicles at highway speeds using IRD's Single Load Cell Weigh-In-Motion, or WIM, scales. Automated License Plate Recognition and Automated Vehicle Identification systems will work in conjunction with the WIM to confirm vehicle credentials and weight compliance. Vehicle information will be gathered and queried against the IRD intelligent Roadside Operations Computer, or iROC, database. Decisions will be made in real-time whether vehicles may bypass weigh stations or report for further inspection. Notification is provided to the commercial vehicle via an in-vehicle transponder and roadside signaling. During peak times, weigh stations often exceed capacity and are forced to close or allow commercial vehicles to bypass the weigh station until the backlog of trucks is cleared. By utilizing IRD's mainline electronic screening and WIM systems, commercial vehicle enforcement facilities can focus on high-risk vehicles, allowing compliant carriers with good safety records to bypass. Not only does this greatly improve the effectiveness of the facility, but it also provides a considerable benefit to the trucking industry by reducing weigh station wait times, fuel costs, and greenhouse gas emissions.
LKSD

Hot Stocks

06:31 EDT LSC Communications acquires The Clark Group - LSC Communications announced that it has acquired The Clark Group. Clark is a leading third-party logistics provider of distribution, consolidation, transportation management and international freight forwarding services, with a network of nine strategically located distribution centers in the US.
ADSK

Hot Stocks

06:25 EDT Autodesk to cut 1,150 jobs in restructuring - In a regulatory filing yesterday, Autodesk commented on its restructuring plan to focus on the company's strategic priorities of completing the subscription transition; digitizing the company; and re-imagining manufacturing, construction, and production. Through the restructuring, Autodesk seeks to streamline the organization and re-balance resources to better align with the company's priorities. By realigning its investments, Autodesk is positioning itself to meet its long-term goals, including keeping non-GAAP spend flat in fiscal 2019.Autodesk plans to reduce staffing levels in the near-term by approximately 13%, or approximately 1,150 positions, and to consolidate certain leased facilities. The company anticipates taking a pre-tax restructuring charge in the range of $135M-$149M. Approximately $91M-$100M in pre-tax charges will be taken in the fourth quarter of fiscal 2018. The remaining charge will be taken in fiscal 2019.
FB

Hot Stocks

06:19 EDT Facebook reports progress in removing ISIS, Al Qaeda-related terror content - Monika Bickert, Head of Global Policy Management, and Brian Fishman, Head of Counterterrorism Policy at Facebook said in a blog post that "Today, 99% of the ISIS and Al Qaeda-related terror content we remove from Facebook is content we detect before anyone in our community has flagged it to us, and in some cases, before it goes live on the site. We do this primarily through the use of automated systems like photo and video matching and text-based machine learning. Once we are aware of a piece of terror content, we remove 83% of subsequently uploaded copies within one hour of upload." They continued, "It is still early, but the results are promising, and we're hopeful AI will become a more important tool in the arsenal of protection and safety on the internet and on Facebook. At the same time, because AI alone is not the answer, we continue to expand our partnerships with other technology companies, governments and nonprofits that share our goal to root out terrorism on the internet." Reference Link
RY

Hot Stocks

06:16 EDT Royal Bank of Canada Chief Risk Officer, Mark Hughes to retire - Royal Bank of Canada announced that Mark Hughes, Group Chief Risk Officer, will retire effective April 9, 2018 after 37 years at the bank. Graeme Hepworth, currently Executive Vice-President, Retail & Commercial Risk, has been appointed Deputy Chief Risk Officer, effective February 1, 2018 reporting to Hughes. On April 9, 2018, Hepworth will assume the role of Group Chief Risk Officer reporting to McKay and he will join RBC's Group Executive as one of ten executives responsible for setting the overall strategic direction of RBC.
GE

Hot Stocks

06:13 EDT General Electric introduces Drawbridge Health - GE introduced Drawbridge Health, a privately-held healthcare technology company focused on enabling personal diagnostic testing - anytime, anywhere. Drawbridge Health is developing proprietary technology designed to integrate draw, collection and sample stabilization into a single device. Healthcare providers will be able to deliver a superior patient experience, eliminating the need for phlebotomy and travel to blood draw centers. This integrated technology is also being developed to support room temperature shipping and streamlined downstream processing, ensuring reliable, accurate results. Through this integration of engineering and proprietary chemistry, Drawbridge Health is developing a people-friendly system for drawing and stabilizing blood samples.
SORL

Hot Stocks

06:02 EDT SORL Auto Parts wins contracts to supply BRT in Shanghai - SORL Auto Parts announced it has recently won major supply contracts from the Shanghai Municipal Transportation Commission. SORL is the exclusive supplier of electric air compressors to all buses for Shanghai's municipal bus route 71. SORL is also the exclusive supplier of electric air compressors to all buses for Shanghai's first Bus Rapid Transit, or BRT, system. In addition to the BRT contract, there are over 2,000 public buses in Shanghai's municipal transportation system currently using electric air compressors made by SORL.
MGCD

Hot Stocks

06:01 EDT Altus Capital commences tender offer for shares of MGC Diagnostics - Altus Capital Partners announced that Altus' affiliate, AC Breathe Merger Sub Inc., has commenced the previously-announced tender offer for all of the outstanding shares of common stock of MGC Diagnostics at a price of $11.03 per share, net to the seller in cash without interest. On November 27, MGC announced that the company and affiliates of Altus had entered into a definitive merger agreement pursuant to which the tender offer would be made. MGC's Board of Directors unanimously approved the merger agreement and the transactions contemplated thereby, including the tender offer and the merger, and recommends that MGC's shareholders tender their shares in the tender offer. The completion of the tender offer is conditioned upon, among other things, satisfaction of a minimum tender condition and other customary closing conditions. The tender offer and withdrawal rights are scheduled to expire at 12:00 midnight, New York City time, at the end of December 27, 2017, unless extended or earlier terminated in accordance with the terms of the merger agreement. Upon the completion of the transaction, MGC will become a privately held company.
E

Hot Stocks

05:59 EDT Eni unit receives federal permit for US Arctic offshore drilling - Achieving American energy dominance moved one step closer today with the approval of Arctic exploration operations on the Outer Continental Shelf for the first time in more than two years. The Bureau of Safety and Environmental Enforcement approved an Application for Permit to Drill Tuesday. Eni U.S. Operating Co. Inc. submitted the application in August. Drilling the exploratory well from a man-made artificial island in the Beaufort Sea is expected to start as early as this December. The Bureau's approval allows Eni to move forward with new exploration in federal waters, but only after a thorough review by BSEE Alaska Region personnel to ensure the request met appropriate technical adequacy, safety and environmental sustainability standards. According to Eni, new exploratory well operations will add an additional 100-110 jobs during the drilling of the well, and any potential plan of development is dependent on the results of Eni's proposed exploration wells. At a minimum, new development could lead to the creation of 100-150 jobs in the region and new production of 20,000 barrels of oil per day. Eni's exploratory drilling will take place on Spy Island, a man-made artificial island approximately three miles offshore of Oliktok Point, in State of Alaska waters. Both the island and Oliktok point are already home to Eni production facilities comprising 18 producing wells, 13 injector wells and one disposal well. Eni is now proposing to use extended-reach drilling techniques to drill into federal submerged lands.
PLM

Hot Stocks

05:17 EDT PolyMet Mining land exchange bill passes U.S. House, advances to Senate - PolyMet Mining announces that House Resolution 3115, the Superior National Forest Land Exchange Act of 2017, today passed the U.S. House of Representatives on a bipartisan 309 to 99 vote and advances to the Senate. The Forest Service authorized an administrative land exchange for the PolyMet Mining NorthMet Project in its Final Record of Decision January 9, 2017. The bipartisan bill, introduced by U.S. Rep. Rick Nolan, D-MN-8 in July, directs the secretary of agriculture to move forward with the land exchange between PolyMet and the U.S. Forest Service. In passing the legislation, the House ratifies the Forest Service's determination that the land exchange is in the best public interest. The bill calls for the exchange to be completed within 90 days of its enactment. "We are grateful to Rep. Nolan, the bill's co-sponsors, and House leadership for their efforts to move this legislation forward," said Jon Cherry, president and CEO. "While neither the legislative nor the administrative exchange would permit or approve construction of the mine, Congressional approval for the exchange provides certainty of process in developing the project by finalizing the land transfer." The terms of the land exchange proposed in the Superior National Forest Land Exchange Act of 2017 are the same as those found in the administrative land exchange: PolyMet receives approximately 6,650 acres of surface land above and around its NorthMet ore body near an area heavily used for mining and mine infrastructure; in exchange, the Superior National Forest receives four parcels of land totaling 6,690 acres currently owned or controlled by PolyMet that will become part of the Superior National Forest. The difference is that the $425,000 equalization payment owed PolyMet by the Forest Service as a result of the administrative exchange would be waived by the company in the legislative exchange.
WFC

Hot Stocks

05:15 EDT Wells Fargo responds to WSJ story, calls it 'misleading' - Wells Fargo strongly disputes the characterization of its foreign exchange pricing as being unfair and unfavorable to its customers, as alleged in a story published by The Wall Street Journal on November 28. "We informed The Wall Street Journal that their story had fundamental inaccuracies before they published," said Wells Fargo Wholesale Banking head Perry Pelos. "We provided pricing data and other information that revealed inaccuracies in the story or that were counter to its negative portrayal of our FX business. Our points and views were either absent in the finished story or not taken seriously by the paper." Points in the story that the company takes issue with include: The assertion that an internal review showed that out of roughly 300 fee agreements only about 35 companies were charged the actual price they had been offered for currency trades is factually incorrect. No internal review leading to that conclusion was conducted by the business. The paper's characterization appears to be tied to unnamed sources and an alleged conference call referenced in the story's opening that could not be verified by our company as having occurred. The Wall Street Journal also implied Wells Fargo is pricing FX transactions in the range of 1% to 4%. The Journal further suggested that such pricing was improper and outside of industry norms, when, in fact, it was explained to the publication that wider-spread outcomes are not uncommon in smaller and lower volume FX transactions, depending on transaction size and type. Such spreads are not reflective of pricing on the full range of transactions, however. Wells Fargo confirmed that the weighted average spread in 2016 for all of its middle market transactions was 18 basis points, which is within the lower end of the middle market range of 15 to 50 basis points cited by the paper. Further, The Journal elected to use a misleading graphic, which showed industry average fees, but disregarded the weighted average volume for Wells Fargo middle market fees, which were provided to the paper. This resulted in an unfair comparison. The Journal, in an attempt to sensationalize what it asserted was a sales-driven culture in the FX business, elected to report that a bell was rung whenever a major sales transaction was completed. Nothing like this has occurred for more than a decade in our FX business - also a fact provided to The Journal - but not included in the story. "While we have made some mistakes in the past, we always work to make it right for our customers, and invite them to reach out to us if they have any issues. But, in our view, the article's characterization of our overall business practices and commitment to our FX customers is misleading and unfair," said Wells Fargo CEO and President Tim Sloan. "We proudly serve thousands of customers in our foreign exchange business and are committed to helping them succeed."
NLSN

Hot Stocks

05:04 EDT Nielsen announces resignation of COO Stephen Hasker - Nielsen last night in regulatory filing disclosed that on November 27, Stephen Hasker, its Global President and Chief Operating Officer, tendered his resignation effective December 31. The company provided no further details.